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Abstract
Staphylococcus pseudintermedius is a Gram-positive bacterial
opportunistic pathogen commonly associated with dermal infections in canines,
but capable of causing serious disease in other species. Reports of human
infections caused by S. pseudintermedius along with an increase in resistance to
multiple antibiotics highlights the importance of this organism. Whole genome
sequencing can allow large scale investigation of genetic mechanisms underlying
phenotypic properties that contribute to the expansion of successful S.
pseudintermedius clonal lineages.
The increase in multidrug and methicillin-resistant S. pseudintermedius
(MRSP) may result from horizontal transfer of genetic material between bacterial
isolates, yet is thought to be rare in Staphylococci and no antibiotic resistance
plasmids have been identified in this organism. Due to conflicting reports of
antibiotic resistance in clinical MRSP isolates, we hypothesized that genes
encoding resistance are carried on mobile genetic elements known to encode
variable degrees of resistance which are difficult to identify using standard
molecular techniques. Whole genome sequencing was performed on six MRSP
isolates, including 3 genomes that were completed and circularized using a
combination of short reads, long molecule reads and optical genome maps.
A total of nine plasmids, six of which contain known antibiotic resistance
genes, were identified from five genomes using a novel plasmid identification
pipeline. Resistance to antibiotics was predicted from genes carried in each
isolate, yet did not match susceptibility profiles generated using standard assays.
Genes encoding resistance to chloramphenicol and gentamicin were located on
mobile elements and displayed delayed resistance in in-vitro susceptibility tests.
When cultured in these antibiotics and re-tested they displayed significant
antibiotic resistance, suggesting standard assay testing time points may be too
short to detect certain types of antibiotic resistance.
v

These findings suggest that horizontal transfer of clinically relevant genes
is common in S. pseudintermedius, and that genome sequencing can be used to
identify mobile genetic elements. Predicting phenotypes from underlying genome
data can reveal potential for antibiotic resistance not identified using
standardized assays.
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Chapter One:
Literature Review
Staphylococcus pseudintermedius is an Important Pathogen
Introduction
Staphylococcus pseudintermedius is a Gram-positive, coagulase-positive
hemolytic bacterium commonly associated with opportunistic infections in
canines (1, 2, 3). However, it has also been isolated from a variety of other
species (4, 5, 6), most recently including humans (7, 8, 9, 10, 11, 12, 13, 8, 14).
Of additional concern to both veterinary and human medicine is the increasing
frequency of multidrug and methicillin-resistant clones (15, 16, 17, 18, 19), often
associated with outbreaks (20, 21, 2). Both methicillin-susceptible S.
pseudintermedius (MSSP) and methicillin-resistant S. pseudintermedius (MRSP)
have been investigated using whole genome sequencing, but to date few studies
have compared predicted antimicrobial genotypes with observed phenotypes.
S. pseudintermedius causes a variety of clinical signs in canines,
particularly in dermal lesions (22,23,3). However, it is also associated with
disease in bovine mastitis (5), rats (6), other animals and humans. S.
pseudintermedius can remain viable on non-animate surfaces such as cell
phones (24) and clothing worn by clinical personnel (25), as well as colonization
and transfer in healthy animals (26, 27) and veterinary staff (28). Co-habitation of
people with animals harboring MSSP or MRSP increases the risk of colonization
of nasal passages of owners (30). There is evidence that co-treatment of
household animals carrying MRSP may be necessary to resolve nasal carriage
or infection of MRSP in humans (13). While treatment of MRSP often involves
use of antibiotics, the rate of detection and isolation of methicillin-resistant S.
pseudintermedius (MRSP) has increased in multiple countries (15, 31, 32, 16,
17, 18, 33, 34, 21, 35, 19), raising concerns about inappropriate use of antibiotics
1

(3, 5, 12, 19) and potential difficulties in treating increasingly antibiotic-resistant
infections (36, 37, 38, 39, 20, 40, 2).
Human infections caused by S. pseudintermedius have only recently been
described (7, 11) and were originally thought to be relatively rare (7), but it is
possible that difficulties in distinguishing between S. pseudintermedius and other
common species of Staphylococcus, such as Staphylococcus aureus (41, 2),
could underestimate the frequency of these infections in the human population
(42, 14, 41, 8). S. pseudintermedius belongs to a group of coagulase-positive
Staphylococcal pathogens commonly referred to as “SIG”, or Staphylococcus
intermedius group pathogens (43). This is both a historical as well as biological
categorization, as until 2005 S. pseudintermedius was not a distinct species (43,
3). S. intermedius and what became known as the SIG organisms were
previously differentiated from S. aureus by lack of pigmentation and inability to
produce acid from maltose (44, 43). However, when the S. intermedius species
separation was proposed in 1976 it was noted that some biochemical reactions
differed from isolate to isolate even within the S. intermedius species grouping
(44). Several biochemical and genetic typing methods exist to identify MSSP and
MRSP (45, 3, 43, 31, 41), however, no single method has been validated as
completely accurate in both positively identifying all S. pseudintermedius while
differentiating from other pathogens, including SIG organisms (46, 47).
Devriese et al proposed in 2005 separating what was then S. intermedius
into two distinct species; S. intermedius and S. pseudintermedius (3). They
justified this primarily based upon DNA-DNA hybridization differences as well as
differential results to other Staphylococcal species like S. intermedius and S.
delphini due to lack of or little maltose acid production and trehalose acidification
(3). From a molecular standpoint, the 16s DNA sequence is>99% identical
across the SIG pathogens (3), and debate exists over the most accurate and
efficient biochemical and molecular typing methods (3, 46, 48, 46, 49). Species
2

determination is a critical aspect of clinical treatment of infection as determining
antibiotic resistance relies upon breakpoints (measurements at which isolates are
determined to be clinically “resistant” to an antibiotic) that can be different
between species and may complicate treatments of MRSP infections (42, 14,
50). The lowest concentrations of an antibiotic at which growth of bacteria is
inhibited is defined as the minimum inhibitory concentration, or MIC. Wu et al,
2015 discovered that some standard testing for methicillin resistance in
methicillin-resistant Staphylococcus aureus (MRSA) applied to S.
pseudintermedius may miss resistant isolates (51). S. pseudintermedius and the
other SIG pathogens may need species-specific MIC breakpoints for accurate
determination of resistance (42). Newer technology such as matrix-assisted laser
desorption ionization–time of flight (MALDI-TOF) may be a solution to better
species-level identification, but it has already been demonstrated that MALDITOF cannot reliably distinguish S. pseudintermedius from S. intermedius (47).
Speciation and Typing
Sequencing 16s ribosomal DNA has become a relatively inexpensive and
fast method for speciating bacteria (52; 53). However, the SIG pathogens have
16s sequences above 98% identity, making this method unreliable for speciation
of these organisms. Many typing methods have been suggested but are often
limited to the population of isolates used in each study (49, 14, 45, 46). Apart
from speciation, attempting to assign relatedness of individual strains within a
species such as S. pseudintermedius has been challenging. Multi-locus
sequence typing, or MLST, is currently the best method for typing S.
pseudintermedius and a 7-gene typing system has been adopted internationally
to assign sequence types, or STs, to S. pseudintermedius isolates (31). MLST
involves sequencing DNA fragments from multiple housekeeping genes (in this
case seven genes) within a genome and using the combination of mutations, or
alleles, to separate isolates into groups. Housekeeping genes are those thought
3

to perform necessary metabolic or other required function for survival, that in
theory are under purifying selection (54). This means that the genes and
mutations chosen should reflect evolutionary relationships, but not take into
account genes responsible for virulence, immune evasion, host adaptation or
antibiotic resistance as these are generally under positive selection (55). While
adequate for determining genetic evolutionary relatedness, MLST often doesn’t
correlate to clinically relevant characteristics. Other genetic tests have been
developed to screen for those attributes such as a PCR screen for the mecA
gene responsible for resistance to methicillin (56) and the beta-lactamase
resistance conferring gene BlaZ (57).
Relevance to Human Medicine
In human medicine, diagnostic laboratories often differentiate Grampositive Staphylococci as either coagulase-positive Staphylococci (CoPS) or
coagulase-negative Staphylococci (CoNS) (58). Gram-positive and coagulasepositive Staphylococci are often assumed to be S. aureus, resulting in antibiotic
susceptibility testing being performed using S. aureus specific breakpoints (48).
However, SIG organisms are also Gram- and coagulase-positive, and recent
reports have suggested that many S. pseudintermedius have been misreported
as S. aureus (7, 14). This can have an effect on assays that determine antibiotic
resistance, potentially miscalling the resistance profile of individual isolates (42).
The first published case of S. pseudintermedius infection in humans was
in 2006; a 60 year old immunosuppressed patient with a S. pseudintermedius
heart infection (7). In 2010, an ST71 MRSP was found to be the cause of a
human eye infection (59), with a similar report indicating S. intermedius that was
likely a S. pseudintermedius (60). Riegel et al in 2011 reported an implantassociated endocarditis caused by S. pseudintermedius likely contracted as a
result of contact with a dog (61). In 2013, a 60 year old male bone marrow
transplant recipient was hospitalized due to purulent lesions discovered to be
4

caused by MRSP, which may have been related to the patients close proximity to
cows and farm dogs (11). A study conducted in 2015 on samples from dog bite
wounds in humans re-examined bacterial isolates originally identified as S.
aureus and discovered that 13 out of the original 101 isolates were in fact S.
pseudintermedius (8). Researchers at the University of California in 2016
revealed that 4 cases of chronic rhinosinusitis, generally assumed to be caused
by MSSA or MRSA, were associated with S. pseudintermedius that shared
similar antibiotic resistance profiles with dogs the patients owned (13). Also in
2016, 24 cases of disease caused by S. pseudintermedius, commonly resistant
to methicillin and multiple antibiotics, were reported by researchers and clinicians
from Canada (62). Viau et al in 2015 concluded that not only is human infection
caused by S. pseudintermedius frequently misidentified, but it is likely much more
common than previously thought due to inaccuracies and regional differences in
standard testing techniques (14). Human cases of both MSSP and MRSP may
be underreported due to inaccurate diagnostic identification. If so, treatment of
these potential cases may be affected by misidentification as antibiotic
susceptibilities could be subsequently misinterpreted (42, 14).
Horizontal Transfer and Spread of Antibiotic Resistance
The discovery and spread of multi-drug resistance (MDR) in almost all
common bacterial pathogens is a serious concern across all medical fields,
prompting the government of the United States of America to create the Task
Force for Combating Antibiotic-Resistant Bacteria (39) which ultimately released
The National Action Plan for Combating Antibiotic-Resistant Bacteria in March
2015 (39). Among the objectives of this Plan are; strengthening the One Health
Initiative and surveillance efforts (One Health being the effort to attain better
health for people, animals and the environment (39)); develop new and
innovative diagnostic tests; develop better capability to identify pathogens;
routine testing for antibiotic susceptibility including zoonotic and animal
5

pathogens and increased validation of antibiotic susceptibility diagnostic tests
(40).
Understanding the spread of MDR is critical for any attempt to combat it.
Traditionally, it is thought that a successful bacterial isolate that can adapt to its
environment better than its peers (in this case acquisition of antibiotic resistance)
will spread clonally and therefore increase overall occurrence of resistance,
which has been observed with a dominant MDR S. pseudintermedius clone
Sequence Type (ST) 71 in many parts of Europe (41). However, in the United
States it appears as though multiple independent clones arise frequently and
spread locally instead of one dominant clone being responsible for the majority of
MDR infections across the country (42, 43).
Despite MRSP ST71 being a dominant clonal lineage in Europe, there are
still many other MRSP clonal lineages both there and in other regions (44, 45).
There are currently over 100 different S. pseudintermedius STs according to the
pubmslt.org website (45), a database that provides information about many
bacterial isolates with regard to their identity relative to different typing schemes,
primarily MLST-7 (46, 47). Of all the S. pseudintermedius isolates in the
database, 45.72% are MRSP (with 54.28% MSSP). With so many unrelated
clones being methicillin and multidrug-resistant, the question arises as to how so
many instances of antibiotic resistance occur independently. The most likely
mechanisms are horizontal gene transfer (HGT) and mobile genetic elements
(MGEs) (48).
Horizontal gene transfer is a generic term for the non-vertical movement of
genetic elements between different organisms. In the case of S.
pseudintermedius, it refers to the transfer of genes or genetic elements from one
bacteria to another outside of normal cell division. As opposed to vertical gene
transfer where a parent cell passes genetic material to its progeny, HGT occurs
between clones that do not share an immediate ancestor, usually via
recombination during conjugation (49). HGT can occur between different clones
6

of the same bacterial species, different species and different kingdoms (50). One
example of HGT is through a genetic construct termed a plasmid. Generally,
plasmids are extrachromosomal, (relatively) small, (normally) circular and (often)
capable of replication independent of the chromosome of its host, in addition to
being capable of transferring between hosts (51). While thought to move
relatively infrequently in Staphylococcal species (52), plasmids play an important
role in gene acquisition for many bacterial species (53) and are a major
contributor to the spread of antibiotic resistance (54).
Mobile genetic elements are the primarily responsible for movement of
genetic material within an individual genome and/or cell, or between cells during
recombination. In addition to plasmids, transposons are segments of DNA within
a genome or extrachromosomal element that can be excised or duplicated to
insert somewhere else in the genome (55). Transposons that contain genes for
antibiotic resistance have been found to duplicate within a genome when
exposed to the antibiotic, thereby increasing gene copy number and resistance to
the antibiotic (56). In one case, this duplication led to a clinical treatment failure
after initial susceptibility testing interpreted the isolated pathogen as susceptible
but eventually developed resistance (32). In addition to increasing gene copy
number through duplication, transposons sometimes replicate inefficiently or
have ambiguous target insertion sequences, leading to mixed, truncated or new
combinations of genes and regulatory elements that can give rise to new or
increased antibiotic resistance which is then transferred to its progeny (47).
MGEs such as those described above are not limited to insertion within its
originating host genome. Most clinically relevant plasmids and transposons
duplicate and recombine/insert/transfer into a second genome during bacterial
recombination, often through conjugation (56). In an early example of spreading
antibiotic resistance, researchers investigating Streptococcus tetracycline
resistance failed to identify known tetracycline resistance plasmids in some
isolates (23, 24); ultimately, they discovered that a conjugative transposon was
7

responsible (23) and that it was even capable of interspecies transfer (21).
Transposons are also capable of integrating onto facilitative plasmids that exist
extrachromosomally in the cell (22).
Plasmids come in many varieties, from those that transfer between cells
during cell division (conjugative plasmids) and those that are mobilizable with the
help of a conjugative plasmid co-located in the cell (54). Generally, plasmids are
considered “dispensable” in that they lack genes essential to the survival of the
cell and instead provide genes or functions that enhance growth or confer a new
function altogether, such as antibiotic resistance. In Staphylococci, plasmids are
thought to be clonally conserved and rarely move between species or even
individual isolates within a species (55). This assumption is based upon both the
lack of observed plasmids through traditional detection methods as well as the
relatively high sequence identity of plasmids that have been found in unrelated
Staphylococci (55). However, this could be an artifact of plasmid detection
methods. A recent study using whole genome mapping discovered the presence
of a previously undetected large plasmid in Providencia stuartii despite lack of
evidence using other traditional methods such as pulse-field gel electrophoresis
(PFGE) (63). Identification of plasmids from genome sequencing data is thought
to be difficult with no currently published methodology. This is due to the fact that
many genome assemblies of bacteria are incomplete, with many unplaced and
fragmented assemblies. Identifying an extrachromosomal element among a sea
of independent DNA sequence assemblies is not possible when the reads
comprising the plasmid cannot be ruled out as part of the main chromosome.
When they are found, plasmids are often identified using searches for
gene sequence identity to known plasmid sequences. As one example of a
common plasmid-seeking method, Lüthje et al. (64) used detection of a known
plasmid gene which confers resistance to lincosamides to screen additional
isolates via polymerase chain reaction (PCR). Isolates positive for the gene were
then amplified and identified using traditional primer-walking or sequencing of
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cloned fragments (64). One reason why we may think plasmids are rare or
lineage-associated in Staphylococci (and other bacteria) is that current detection
methods are unlikely to reveal novel or low copy number plasmids. PCR
detection of a plasmid relies upon a known gene with limited natural variation of
the primer sequences. This ensures that novel or highly variable plasmids are not
likely to be found, potentially underrepresenting overall plasmid carry rates. As
the sequence of the gene must be very similar to the sequence used to search, it
is likely that plasmids found using that sequence are also conserved across the
rest of the plasmid, ensuring that they all seem highly phylogenetically related
and thus infrequently transferred. Detecting novel plasmid sequences or
combinations of plasmid sequences/genes without prior knowledge is certainly
challenging, but as most genome sequencing amplifies all DNA in the cell
unambiguously, novel plasmid sequences should be represented in the data. As
plasmids are often found at higher copy numbers in individual cells than the main
chromosome, plasmids may represent higher read copy numbers from whole
genome sequencing (WGS) data than genes located intrachromosomally and
identified using this characteristic.
Bacteriophage (and subsequently prophage) are a type of virus that
infects bacterial cells and can technically represent both HGT and MGEs (56).
When a bacteriophage infects a bacterium, it can follow two different life cycles.
Virulent phages integrate themselves into the host genome, replicate using host
machinery (and potentially their own) and eventually lyse the infected cell.
Temperate phages are capable of a lytic cycle but also a lysogenic cycle where
they incorporate themselves into the host chromosome yet remain dormant
without lysing the cell, passing on to daughter cells during replication and
division. Bacteriophage that are located on the chromosome can replicate
themselves and transfer horizontally (67), which in addition to the normal viral life
cycle represents a significant mechanism for the movement of genes between
bacteria (68). Lysogenic phage often carry a variety of genes not necessary for
9

their own life cycle, but are indirectly beneficial by providing their host with
increased survivability (69). Antibiotic resistance (70) and genes encoding
virulence factors (71) are commonly associated with phage content in
Staphylococci (72), and the benefit these genes carried by the phage provide can
increase survivability of the host and lead to expansion of the infected strain. A
particular phage, known as Phage Mu, has even been shown to confer host
adaptation to human infection of animal-associated pathogens (45, 78).
The idea that MGEs such as plasmids, bacteriophage and transposons
are infrequently transferred and are thus mostly lineage-associated in
Staphylococcus has been challenged by at least one recent study, which differed
from many MGE investigations in that it sought to determine the rate of transfer
of MGEs in vivo in guinea pigs (4). McCarthy et al. in 2014 used gnotobiotic
piglets combined with WGS to detect in vivo transfer of transposons, plasmids
and prophage from two Staphylococcus aureus strains of human origin.
Interestingly, one of the strains used, S0385, was isolated from a human
infection but was the first CC398 isolated to have its full genome sequenced and
annotated (65) and represents a clonal lineage commonly associated with
porcine origin; thus, the study also implicated transfer of MGE between animal
and human pathogens. Each S. aureus strain had its own unique compliment of
MGEs, comprising phage, a transposon and multiple plasmids. Gnotobiotic
piglets were inoculated with both strains, swabbed at multiple time points and
colonies sequenced using the Ion Torrent Personal Genome Machine (Ion PGM)
to determine their natural rate of co-evolution as well as transfer of any of the
previously identified MGEs between the two parent strains (4).
While the core genomes of the two strains over multiple days stayed
relatively identical to the parent strains, loss, gain and transfer of MGEs was
observed at the earliest time point screened- 4 hours. By day 2 of the
experiment, one of the parent strain populations had arranged itself into 9
unique, individual compositions of MGEs, or “mobilomes”. Movement of the
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transposon was not observed for any of the progeny isolates throughout the
experiment. These results suggest that plasmid mobilization occurs more
frequently than movement of phage, and far more frequently than transposon
movement in their in vivo environment. These same two S. aureus strains grown
together in a liquid in vitro equivalent parallel experiment revealed that the
majority of progeny retained the original mobilome of their parents, suggesting
that some unique characteristic of in vivo growth contributes significantly to the
movement of MGEs. Thus, the lack of observed movement of MGEs in a
laboratory setting could be an artifact of the relatively few in vivo growth
experiments investigating this phenomenon. (4)

Advances in Whole Genome Sequencing
Introduction
Whole Genome Sequencing (WGS) traditionally has been interchangeable
with the term “next-generation sequencing” (NGS); however, with the advent of
2nd, 3rd and 4th generation technologies using new mechanisms or improved
hardware this has fallen out of use (56). Genome sequencing is distinguished
from “traditional” or “capillary” sequencing as it uses non-electrophoretic methods
to sequence vast amounts of DNA in relatively short periods of time compared to
standard capillary DNA sequencing (56, 57). The megabase or gigabase output
of these technologies are so high compared to traditional sequencing that they
are termed “genome-level” sequencing, as individual experiments can sequence
so much DNA it is possible to represent the entire genomes of many organisms
(76). Initially, the cost of this mass sequencing of simultaneous, multiple DNA
fragments was prohibitively high for any but large consortiums or laboratories
(34). However, over the last several years the cost of the technologies
themselves as well as reagents have been significantly reduced as WGS has
become ubiquitous across multiple disciplines of biology (23). Genome
sequencing technology is being used for a wide variety of applications in addition
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to revealing the entire DNA composition of an organism; gene expression and
transcriptome analysis (78), real-time clinical diagnostics (79), mass
spectrometry protein identification (34), microbiome analysis (12) and cancer
screening and detection (45).
Introduction to Sequencing Technologies
There are several WGS technologies currently available that have variable
sequencing methodologies, costs and data output differences (Table 1). The two
technologies primarily used in this work were the Illumina MiSeq (Illumina Inc.,
San Diego, CA) and Ion Torrent (Thermo Fisher Scientific, Inc, USA).
Additionally, some isolates were sequenced using PacBio single-molecule realtime (SMRT) sequencing technology (Pacific Biosciences, Menlo Park, CA, USA)
and had Whole Genome Maps made using the Argus system (Opgen, Inc, MD,
USA).

Table 1. Properties of Major WGS Technologies in Bacterial Genome Sequencing.
Whole genome sequencing technologies evolve at a rapid pace. The Roche 454, the
first of such technologies, is now defunct while the MinIon device is the newest
generation capable of 100x the read length and >100x the output of the 454. The Ion
Torrent produces single reads of >450bp whereas the MiSeq produces 2x300bp paired
reads. PacBio sequencing is low quality and expensive but produces extremely long
reads. Each technology produces high throughput DNA sequencing data yet can
address different genome assembly failures.
Read
Read
Technology Quality Length
Type
Multiplex Cost/genome
454*
high
500-750 bp
Single
N/A
N/A
Ion Torrent
high
~450 bp
Single
12 to 24
~$550.00
Paired
MiSeq
high
~300x2 bp
End
up to 96
~$300.00^
Long
PacBio
low**
1Kb-20Kb
Read
unknown ~$1000.00
Long
MinIon
low
5Kb-50Kb^^ Read
unknown unknown
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The Illumina sequencing platform uses sequencing-by-synthesis (SBS)
technology (66) to determine the order of individual base pairs as they are
synthesized. Essentially, single-strand DNA fragments are linked to a flow cell
surface through random oligonucleotides, with primers and polymerase added to
fuel the synthesis of the second strand. The individual dNTPs are fluorescently
labeled (dye) as well as having a 3’ reversible blocker which prevents additional
base pairs from being added. Upon the addition of a base pair, the chip is
imaged by a camera to capture the fluorescently-labeled bases, a deblocking
step removes the 3’ blocker and dye and the next step repeats the first,
eventually building an ordered DNA sequence. By doing this thousands to
millions of places at the same time, massively parallel sequencing is achieved
(66).
Ion Torrent technology uses a different type of SBS called ion
semiconductor sequencing (67), in which hydrogen ions released during addition
of base pairs to a growing DNA strand are measured by a detector that translates
the electrical charges into their corresponding base additions (67). One major
difference between the Illumina technology and Ion Torrent is that no cameras,
optics or modified dNTPs are used; the added base is detected through a change
in pH resulting from the release of the hydrogen ion using an ion-sensitive fieldeffect transistor (ISFET)(67).
Single molecule real time sequencing, or SMRT, is a real-time WGS
method that has significantly longer output read lengths than other technologies
(68). It works through the utilization of a device called a zero-mode waveguide, or
ZMW (68). A ZMW is a photonic confinement structure that captures light
wavelengths in a small enough area to detect single nucleotides incorporating
into a DNA strand. Essentially, a DNA polymerase enzyme/DNA strand complex
is attached to a ZMW in a confined area and flooded with fluorescently labeled
dNTPs. It is considered real-time sequencing because as dNTPs are added
naturally by the polymerase, the phosphate bridge attaching the dye is broken,
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releasing the dye and causing a change in the light wavelength detected by the
ZMW- without the need to stop the enzymatic action of the polymerase. This
technology has achieved extremely long read lengths of >20,000 base pairs (68).
Whole Genome Mapping (WGM), previously called optical genome
mapping, was pioneered by Dr. David Schwartz at NYU, Madison in 1993 as an
attempt to image individual DNA molecules cut with restriction enzymes for
comparison with DNA sequencing results (69). DNA sequencing is actually not
performed; instead, WGM is used as a scaffold for assembling WGS data to
create far more accurate and closed genomes (70-72). In brief, extracted high
molecular weight DNA (usually >150,000bp) is applied to a chip etched with
nano-scale channels along with a fluid in order to flow the DNA molecules
through the channel and “stretch” them out. Once electrostatically bound to the
chip, restriction enzyme solutions are applied to cut the laid out DNA molecules
at specific “cut sites”. This causes the DNA molecules to retract slightly, as if
cutting a rubber band, while still being adhered to the chip surface. Last, a
universal DNA fluorescing dye is added to illuminate the DNA fragments. A laser
or ultra-high definition camera then images the positions of the DNA fragments in
relation to each other; meaning that multiple DNA fragments from the same
original molecule are measured and annotated with cut sites (71). The images
are converted into digital representations (Figure 1, 72) and assembled in a
process analogous to WGS assembly by matching cut patterns in the molecules
against each other to produce a complete, ordered restriction map of the entire
genome (72). These “optical maps” can be used to assist with assembly of WGS
data, as artificial “optical maps” can be generated from sequencing contigs in
vitro and aligned with the map to ensure proper placement and arrangement (7072).
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Figure 1.Optical Images of DNA Molecules are Converted into Digital Representations.
Source: Riley et al., 2011.

Uses and Limitations of Whole Genome Sequencing Data
While access to genome sequencing technology has become more
widespread and less costly despite significant advances in capability, there are
still limitations that must be kept in mind depending on intended use. In the case
of sequencing the genome of an individual bacterium, the first fact to take into
account is that, for the vast majority of sequencing protocols, it is not a single cell
being sequenced but several hundred to millions of generations of cells grown in
a specific environment. DNA intended for WGS is extracted from either liquid
media cell cultures or colonies of cells isolated and grown on media impregnated
plates. While this ensures the extraction of the quantity and quality of DNA
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needed for sequencing, the artificial growth conditions as well as subsequent
rounds of culture can influence genome content (73).
In addition to the influence of bacterial culture on genome content,
assembly of WGS data is complicated by repetitive DNA sequences found
throughout the genome (74). Prophage insertions and transposons represent a
challenge for genome assembly that does not currently have a solution. While
paired-end sequencing (Illumina) was introduced in an attempt to resolve smallscale repeats, recent studies have shown that paired-end reads can actually
introduce errors, especially in genomes with high levels of repetitive elements
(74). Considering the fact that many clinically relevant features of bacterial
isolates, such as antibiotic resistance, are carried on MGEs (70; 75) (such as
transposons or phage) that can be highly repetitive, misassembly or failed
assembly of these elements can have profound effects on conclusions taken
from WGS data.
Because sequenced genomes often contain unexpected genes and
mutations that cannot be predicted, specific questions must be asked when
pursuing WGS projects. Subsequent analysis of sequenced DNA can be used to
help develop tests that can then be standardized. For example, observations of
antibiotic resistance can be used to target genomes for sequencing, which when
compared to related genomes may allow for identification of the genetic
determinants of resistance (76). Once the sequence of a suspect gene is known,
simple, PCR-based assays can be developed to screen additional isolates
without the need for complete genome sequence (77). Thus, WGS can serve as
a guideline for new assay development. This has been used to great extent with
the development of microarrays, databases and repositories such as the
Comprehensive Antibiotic Resistance Database (76-78,
https://card.mcmaster.ca/).
Finally, inferring clinically relevant characteristics about bacterial isolates
using WGS technology largely depends upon the correct annotation of
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assembled genome data. Functional annotation generally consists of comparing
predicted coding sequences (CDS) against DNA and protein sequences that
have already been assigned functional characteristics and have been made
publically available such as those in GenBank (79, 80). There are significant
variations in how different annotation pipelines operate, which leads to
differences in assigned gene functions. Currently, the most cited annotation
software for bacterial genomes with published Genome Announcement articles is
the Rapid Annotation using Subsystem Technology server (81, RAST:
http://rast.nmpdr.org/). Recently the National Center for Biotechnology
Information, which hosts one of the largest international databases for biomedical
and genomic information, has released the NCBI Prokaryote Genome Annotation
Pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_prok) which produces
output files directly compatible with submission guidelines for deposition of
sequence data into publically available online databases (82).

Summary and Hypotheses
As genome sequencing technologies continue to reveal the complete
underlying genetic background of microbial pathogens it will become easier to
understand the relationships between genetic markers within a pathogen as well
as between pathogens. Uncertainties in assembling and annotating whole
genome sequence data necessitate asking directed scientific questions when
undertaking WGS projects. Clinical, molecular and epidemiological data is
routinely collected on clinical isolates of Staphylococcus pseudintermedius at the
University of Tennessee College of Veterinary Medicine (UTCVM). Having this
data available facilitates the generation of testable hypotheses that can be
addressed using a variety of WGS technologies.
Understanding clonal expansion of successful S. pseudintermedius
lineages assists in determining important virulence and growth factors. Currently,
the MLST-7 typing system with eBURST analysis (83) is the best method for
determining MRSP and MSSP clonal relationships. As this system utilizes
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mutations within seven housekeeping genes to determine relatedness, it should
accurately reflect evolutionary divergence of the core, or required, gene set.
Sequencing the entire genome of S. pseudintermedius isolates can reveal the
entire core genome DNA and phylogenetic analysis using this data should mimic
the MLST-7 relationships. Isolates from the same sequence type but isolated
from separate geographic locations should have nearly identical core genomes,
while isolates from the same region but of different Sequence Types should
diverge from each other. These analyses use conserved DNA sequence and are
unable to account for horizontally transferred genetic elements that often encode
host adaptation genes, virulence factors and antibiotic resistance (4; 55; 84). As
horizontally transferred mobile genetic elements (MGEs) require close proximity
for movement between bacteria, it is hypothesized that their MGE content may
group more geographically than along evolutionarily related lineages revealed by
core genome analysis. Whereas whole genome sequencing strategies often
have difficulty resolving these areas due to repetitive DNA structures (85), optical
genome maps and long molecule sequencing may help assemble these areas
(70).
Disagreements in antibiotic susceptibility profiles (ASPs) have been
observed when isolates are tested using different methods. Antibiotic disc
diffusion and automated testing using microbroth dilution via the Vitek system
vary in their protocols and it is not unexpected that results can vary (86, 51, 87).
For example, it has been observed that high-level resistance (HLR) to gentamicin
is mediated by the aac(6’)-aph(2’’)-Ia gene (88), however a small number of
Staphylococcus epidermidis isolates, which are closely related to S.
pseudintermedius, can have this gene yet be determined susceptible to
gentamicin using standard testing methods (89; 90). When these isolates were
grown in the presence of gentamicin increased resistance was observed,
suggesting that an unknown mechanism was responsible for an inducible
resistance phenotype (89). As horizontally transferred genetic elements such as
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plasmids and phage can have variable gene copy number and expression (91),
antibiotic resistance may be mediated by duplication of these genes within
heterozygous cell populations. As genes found on plasmids have been known to
increase antibiotic resistance by increasing plasmid copy number when exposed
to selection or stress (92), it may be possible that variation in plasmid copy
number per cell and not the greater population could influence phenotypic
resistance.
Differences in antibiotic resistance observed for MRSP isolates using the
two assays may be a result of mixed populations of bacteria with differing
degrees of antibiotic resistance based upon gene copy number or regulation.
Populations would differ in genomic content in order to provide the best fitness as
a culture; those adapted for growth in selection may not be most efficient at nonselective growth. A major difference between the testing methods is the duration
of time bacteria are exposed to antibiotics before a reading is taken. In disc
diffusion, tests are read at 24 hours for this species while the Vitek instrument
interprets results in as few as 4 hours. If isolates show resistance using disc
diffusion but not in the shorter timeframe of microbroth dilution, it may reflect the
inability of mixed cell populations to adapt quickly to the selective environment.
These cultures should display increasing resistance if exposed to the antibiotic in
question over longer periods of time as the small subset of highly resistant cells
outcompetes less resistant cells in the population. Genome sequencing can
reveal the underlying genetic components of antibiotic resistance such as the
aac(6’)-aph(2’’)-Ia gene. Isolates with differences in testing results for resistance
to gentamicin may contain this or other resistance genes; if so, extended growth
in antibiotics will increase observed resistance. Re-testing isolates found able to
grow in higher concentrations of antibiotics than initial testing would provide
evidence for potential clinically relevant resistance. Therefore, isolates shown to
have genotypes for resistance that are not reflected in their phenotypic testing
are hypothesized to become resistant when allowed to adapt to a selective
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environment. This induced resistance should then be capable of detection using
standard assays and reflect heterozygous cell populations.
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Chapter Two:
Genome sequencing of Staphylococcus pseudintermedius
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Abstract
Staphylococcus pseudintermedius is a pathogen of multiple host species
with increasing frequencies of resistance to methicillin and multiple antibiotics.
Understanding the spread of successful clones and transfer of antimicrobial
resistance is important in disease prevention and treatment. Isolates collected
across North America were characterized using standard biochemical and
antimicrobial susceptibility testing in addition to genetic epidemiologic
investigation. While informative, this information does not always provide a
complete understanding of evolutionary relationships and horizontal transfer of
genetic elements in this species. Particularly, few prophage and no plasmids
have been found in this species to date, yet are known to contribute to overall
antibiotic resistance and virulence in many bacterial species. While two genomes
had been published at the start of this study, they represent methicillinsusceptible S. pseudintermedius (MSSP) and are not closely related to North
American clonal lineages.
To better understand genotypes and representative phenotypes of North
American methicillin-resistant S. pseudintermedius (MRSP) isolates, 30 MRSP
and 6 MSSP were selected for whole genome sequencing. Isolates were
selected representing dominant clonal lineages, isolates with conflicting antibiotic
susceptibility profiles and unusual or unique lineages for comparative purposes.
Whole genome sequencing was performed using four different technologies
along with optical genome mapping to resolve the best genome assemblies
possible. Genome data were analyzed for core genome relationships, genes
contributing to antibiotic resistance and presence of horizontally transferred
elements.
Complete, circular genomes were produced for 4 MRSP isolates and
assemblies were produced averaging under 100 contigs for the remaining
MSSP/MRSP. Out of 120,378 coding sequences predicted from genome content,
838 were found to have predicted contribution to resistance to antibiotics or
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disinfectants. More than 25 extrachromosomal plasmids were identified using a
novel prediction pipeline and 20 intact or incomplete prophage were detected
from the dominant clonal North American lineages. Core genome analysis upheld
previous typing relationships, yet accessory genomes were found to be highly
unique and almost entirely composed of horizontally transferred elements such
as transposons and bacteriophage. Antibiotic resistance genes were found to
reside on plasmids, prophage and transposons in addition to the core genome,
and were not conserved within individual lineages.
This study is the first to report extrachromosomal plasmids in S.
pseudintermedius and reveal that 10-20% of MRSP genomes are composed of
non-lineage associated mobile genetic elements. Previous studies have
suggested plasmids are rare and horizontal genetic elements such as plasmids
and phage are conserved within lineages in the Genus Staphylococcus. This
study suggests that horizontal transfer of mobile genetic elements is not only far
more frequent than expected but also plays a role in antibiotic susceptibility that
may bely phenotypic testing assays.

Introduction
Applications of Whole Genome Sequencing
Genome sequence data has become a valuable tool for biomedical
research and clinical investigation. In 2014, Hasman et al published a method by
which microbial pathogens can be detected and characterized directly from
samples submitted to a clinical microbiology laboratory using WGS technology
(93). Amazingly, not only were MLST and other traditional typing methods in
agreement when comparing the shotgun metagenome samples to cultivated
bacteria from the same samples, but predicted antibiotic susceptibilities matched
for 17 of the 19 bacteria identified (93).
Prior to this study two S. pseudintermedius genomes were publically
available; ED99 and HKU10-03 (94,95). While both of these strains were
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resistant to some antibiotics, they were not MRSP, were originally isolated
outside of North America and are not typical of the major clonal lineages in
circulation globally today. Thus, efforts to sequence MRSP genomes from
currently circulating clonal lineages, particularly the most clinically problematic
MRSPs, were undertaken. New WGS data from dominant MRSP types would
provide in-depth epidemiological and molecular data to ascertain the
mechanisms responsible for these successful pathogens.
Bacteria are routinely collected and characterized from both infections as
well as for routine collection of North American S. pseudintermedius isolates.
Biochemical analysis as well as molecular typing and antibiotic susceptibility
profiling are conducted for studying molecular, phylogenetic and epidemiological
characteristics of this organism to learn more about its success and spread,
acquisition of multidrug resistance and qualitative risks to animals and humans
(35, 45).
Two primary characteristics were considered in determining which
bacterial genomes to sequence. First, a large-scale MLST-7 typing was carried
out on a collection of hundreds of North American (NA) S. pseudintermedius
isolates (34), followed by an eBURST analysis to determine genetic relatedness
(65, 79). Based on the work of Videla et al, six isolates were identified belonging
to dominant MRSP clonal lineages, or Sequence Types (STs), in North America
and selected for genome sequencing to determine true genetic relatedness and
gene content (Figure 2):
1.
2.
3.
4.
5.
6.

08-1661 belongs to ST71
06-3228 belongs to ST68
NA45 belongs to ST84
NA47 belongs to ST303
NA12 belongs to ST64
NA07 belongs to ST124
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Figure 2eBURST Analysis of North American Collection of Staphylococcus
pseudintermedius. (Manuscript in preparation).
Mutations in housekeeping genes identified using MLST-7 determine evolutionary
relationships using the eBURST software. The three central points represent ST84,
ST68 and ST71 and their expanded lineages. Respective representatives of these STs
are NA45, 06-3228 and 08-1661 which were selected for genome sequencing.

Second, antibiotic susceptibility profiles (ASPs) were analyzed for these
isolates to investigate similarities or differences that may exist in their resistances
that could be related to their STs. While no pattern was observed linking ST to
ASP, most of these isolates had unique ASPs. Interestingly, some isolates had
discrepancies between disc diffusion and microbroth dilution
interpretationssusceptibility results (S=susceptible, R=resistant) for specific
antibiotics (Table 2). For these reasons these isolates were sequenced.
Sequencing the genomes of these isolates allows for analysis of true divergence
between genomes relative to MLST/eBURST and PFGE and reveals genetic
elements responsible for their ASPs, resolving the discrepancies between their
resistances via different testing methods. Isolates selected for additional
sequencing were chosen due to biochemical abnormalities, unique ASPs,
ambiguous speciation, comparative purposes or conflicting results between
resistance to methicillin and mecA content (Appendix A).
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Table 2. Antibiotic Susceptibilities of Isolates Selected for WGS.
Isolates 08-1661 and 06-3228 were selected for whole genome sequencing due to
observed conflicting susceptibilities as reported by standard assays. NA12 and NA07
were additionally sequenced as they belong to clonal lineages with high levels of
resistance to gentamicin and clindamycin.
Disc
Isolate
Antibiotic
Vitek
Diffusion
08-1661 Chloramphenicol
R
S
08-1661

Gentamicin

I

S

08-1661

Clindamycin

R

R

06-3228

Chloramphenicol

S

S

06-3228

Gentamicin

S/I

S

06-3228

Clindamycin

R

R

NA12

Chloramphenicol

S

S

NA12

Gentamicin

S

S

NA12

Clindamycin

S

S

NA07

Chloramphenicol

S

S

NA07

Gentamicin

S

S

NA07

Clindamycin

R

R

Isolates 06-3228, 08-1661 and NA45 were manually assembled and
curated for this project because they represent the top 3 dominant lineages of
MRSP in the United States, and closed genomes were obtained in order to
identify complete SCCmec elements as well as prophage, plasmid and
transposon content. Isolate 08-1661 was sequenced a third time after exposure
to chloramphenicol, an antibiotic it was previously determined to be resistant to
via disc diffusion yet susceptible in microbroth dilution assays (Appendix A:
Antibiograms; Table 2), to determine any effects the exposure may have on the
underlying genetic elements responsible for resistance.
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Methodology
DNA Extraction and Library Preparation
All µL isolates sequenced during the course of this study using Ion Torrent
or Illumina MiSeq technologies were grown in TSB overnight at 37°C and
harvested during log phase growth. The Epicentre® MasterPure Gram Positive
DNA extraction Kit (CAT #: MGP04100, www.epibio.com) manufacturer’s
protocol was followed, with modifications (Appendix B: Modified Protocols).
Briefly, 2mL overnight growth was centrifuged at 6000g for 6 minutes and
suspended in TE buffer. Lysis was performed using 2x the recommended
amount (2uL per sample) of Ready-Lyse Lysozyme (CAT #: R1802M,
epibio.com) with addition of 2µL lysostaphin (CAT #: L7386-1MG,
sigmaaldrich.com). Samples were incubated at 37°C for 3 hours before addition
of lysis solution and twice the recommended (2uL) Proteinase K (kit
components). Samples were incubated at 70°C for 15 minutes, cooled to 37°C
and transferred to ice. 200µL of MPC reagent was added and gentle tube
inversion used to mix the sample, on ice, before centrifuging at 10000g for 10
minutes. 2µL RNAse A was added to each sample and incubated for 30 minutes
at 37°C. DNA was precipitated from the solution by addition of 650µL ice-cold
99% isopropanol and tube inversion until white DNA precipitate was observed.
The solution is centrifuged again at 10000g and 4°C and supernatant discarded,
the remaining precipitate was washed with 70% ethanol on ice. Upon removal of
excess ethanol through an additional centrifugation (short spin) and micropipette,
DNA was eluted using 200µL sterile, DNA and RNA-free water. Samples were
stored at -20°C until needed.
Library preparation for Ion Torrent sequencing was performed by Ellen
Messenger using the Ion Torrent Library Prep Kit (CAT #: E6285S, NEB) per
manufacturers protocol. Sequencing on the Illumina MiSeq was performed using
either the Nextera XT DNA Library Prep Kit (CAT #: FC-131-1024, Illumina.com)
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and Index Kit (CAT #: FC-131-1001, Illumina.com), or the Qiagen FX DNA
Library Kit (CAT #: 180473). As the Illumina manufacturers protocol was
designed for doing 24 or 96 samples in a plate, the protocol was modified and a
custom protocol developed (Appendix B: Modified Protocols) to optimize both
individual tube sample processing as well as to minimize use of AMPure
Magnetic Beads (CAT #: A63880, beckmancoulter.com). DNA extractions were
diluted to 1ng using sterile water and tested for purity using a fluorimeter prior to
input into the Nextera modified protocol. DNA input concentrations up to 10ng
were also used, with no discernable difference in library output. Samples
prepared with the Qiagen kit were completed according to manufacturer’s
protocol (https://www.qiagen.com/us/resources/download.aspx?id=6f2989618e3d-4235-b5b1-5a3a3394dbb0&lang=en).
Additionally, Whole Genome Optical Maps (Opgen, Inc., MD) were
generated for isolates 06-3228, 08-1661, and NA45 and PacBio SMRT long-read
sequencing (Pacific Biosciences, CA) was performed on 06-3228 and NA45.
Data Assembly and Analysis
Data from Ion Torrent and MiSeq technologies were analyzed, filtered and
used for de novo as well as reference genome read-mapping using the
bioinformatics software Geneious® v.9.1.3. Reference genomes included the
MRSP ST71 isolate E140, MSSP isolate ED99 and MSSP isolate HKU10.
PacBio reads were assembled using the beta-test long-read molecule assembly
software in CLC Genomics Workbench v.9.0. Contigs from CLC were imported
into Geneious for combined assembly with Ion Torrent and MiSeq data. Multiple
assembly pipelines and parameters were optimized for this organism and used to
generate de novo assemblies (Table 3) for each genome. The default assembly
software in Geneious® performed the best giving the highest number of large
contigs and estimated genome coverage for almost all assemblies. For this
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species, all software used for assembly utilized between 250,000-550,000
maximum number of reads per sample for optimal contig creation.
Optical maps were used to scaffold consensus sequencing contigs with in
silico AflII cut sites for strains 06-3228, 08-1661, NA45, NA12, E140, NA47 and
NA07 (Figure 3). Using the published genomes of HKU and ED99 as scaffolds
for read mapping was useful in placing contigs in order, yet were not used
directly to map reads to generate consensus contigs as they would often
introduce incorrect errors relative to de novo contig assemblies (Figure 4).
Long Sequencing reads from Pacific Biosciences sequencing were
assembled into consensus contigs and used as references for mapping MiSeq
paired end sequencing reads for contig correction and increased accuracy and
compared to de novo contigs from MiSeq read assemblies. Large (~500010,000bp) errors were occasionally observed between PacBio de novo contigs
and MiSeq de novo contigs. In these cases, comparison to the optical maps
demonstrated that the MiSeq de novo contigs matched most closely and
therefore those contigs were used for final assembly and gap closure. Upon
manual assembly investigation it was observed that during the PacBio short-read
correction step in the CLC Workbench assembly pipeline, short reads spanning
into large repeats such as RNA operons or prophage insertions were often
misplaced at the 3’ or 5’ end yet used to “correct” the long read erroneously.
Thus use of the MiSeq de novo contigs to correct erroneous PacBio contigs
produced the most accurate assembly. Using the optical genome maps, the
genomes of 08-1661, 06-3228 and NA45 were closed with no observed gaps in
circular arrangements, with small areas of sequencing disagreement represented
as ambiguities but without affecting the overall assembly.
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Table 3. Genome Assembly Parameters.
Whole genome data was analyzed using multiple software packages and assembly
algorithms. The software Geneious with its specific assembler produced the best de
novo assemblies using these parameters for read trimming and extraction, contig
assembly and consensus contig generation. Individual parameters were optimized
through multiple rounds of manual investigation and assembly; all assemblies were
produced de novo without the use of reference sequences.

Read Extraction and Trimming
Extract 500000 reads for assembly
Trim 5' and 3' ends with 5% error probability limit
Assembly Parameters
Merge homopolymer variants during assembly
Allow maximum of 10% gaps per read
Maximum gap size= 2bp
Allow 20% maximum mismatch per read overlap
Index Word Length= 18-20
Index word size= 13-15
Index maximum ambiguities= 4
Generating Consensus Contigs
Circularize contigs with matching ends
Don't merge read variants with coverage over 6x
Generate consensus using majority threshold per site
Ignore assembly gaps
Assign highest quality per base in consensus
Split consensus if coverage drops below 4
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Figure 3. The use of Optical Genome Maps as Genome Scaffolds.
Optical genome maps were generated by imaging DNA molecules digested with a known
restriction enzyme resulting in a digital representation of the whole genome with correctly
ordered AflII cut sites. De novo genome sequencing contigs were artificially cut in silico
and cut patterns of individual contigs were aligned against the optical map to determine
correct placement and orientation. These maps along with PacBio long read technology
were used to generate complete, circular genomes for 4 MRSP isolates.

Contigs or closed genomes were annotated using the RAST server
(http://rast.nmpdr.org/) and/or the NCBI Prokaryote Genome Annotation Pipeline
(http://www.ncbi.nlm.nih.gov/genome/annotation_prok). Annotated genomes
were imported back into Geneious® in Genbank format for comparative genomic
and content analysis. Specific genes of interest were manually investigated using
protein domain and orthologous sequence searches. Resfinder (80) and the
CARD database (96) were used to predict antibiotic resistances, MAUVE (97)
was used for direct genomic content comparison, EDGAR (98) was used to
perform core genome analysis and phylogenetic comparisons, and PHAST (99)
was utilized to identify active and inactive prophage insertions.
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Figure 4. In silico AflII Optical Maps Generated from Reference Genomes are Inaccurate
for Spanning Contig Assembly Gaps.
Read mapping to previously sequenced reference genomes was avoided during
assembly as it often could not resolve or misrepresented gaps in de novo assemblies. In
assembling the E140 genome, small sequencing contigs with AflII cut patterns matching
patterns in the true optical map were able to span a gap between two larger contigs.
This area would not have been accurately assembled if either the HKU or ED99
reference genomes had been used, as seen by their unique cut patterns for that region.

Small extrachromosomal elements (such as plasmids) were identified from
sequencing data using two methods. First, small (<6000bp) contigs that had read
depth coverage significantly higher than that of the draft genome average were
analyzed (Figure 5), and manually investigated using a self-BLAST to see if they
had reverse compliment terminal regions that could circularize the contig. If so,
the contig was manually trimmed and circularized at these areas, and read
mapping was performed to show continuous reads in a circular arrangement
around the potential plasmid. This workflow is summarized in Figure 6.
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Figure 5. Above Average Depth of Coverage Indicates Potential Plasmid Sequence.
Contigs assembled de novo from WGS reads of approximately the same length should
be comprised of similar numbers of reads. Occasionally, contigs with abnormally high
read coverage were observed, indicating higher original copy number of these
sequences relative to the genome average.

Consensus contigs identified as potential extrachromosomal elements
were iteratively mapped with the original sequencing reads to confirm either
independent circularization or genomic integration.

Results and Discussion
Genome Sequencing
Library preparations were inspected for fragment sizing and quantified on
the Agilent Bioanalyzer (CAT #: G2940CA). In summary, libraries prepared with
the Illumina kit had average fragment size range between 300bp and 600bp,
whereas the Qiagen libraries were generally between 600bp and 1000bp.

33

Figure 6. Manual Investigation of Genome Sequencing Data for Identification of Plasmid
Sequences.
A workflow was developed to rapidly identify potential extrachromosomal plasmids from
raw WGS data utilizing the concept that plasmids are often found in higher copy number
per cell than the main chromosome. Genome assemblies were screened for higher than
average depth of coverage for contigs of a given size. Successful circularization of high
read number contigs was indicative of plasmids, which were analyzed for gene content
and function.

Interestingly, final sequencing data did not seem affected by this variation
as de novo assemblies produced similar results across all isolates. Likely this is
due to the lack of using paired-end assemblies, as pairing the reads from the
MiSeq runs consistently produced inferior contig assemblies than using them
unpaired which has been observed previously (64). Almost all isolates
sequenced, regardless of technology used, resulted in initial de novo genome
assemblies of less than 250 contigs (Table 4).

34

Table 4. Genome Sequencing Statistics for All Isolates.
Clinical isolates representing dominant clonal lineages of S. pseudintermedius in
North America were sequenced to investigate their antibiotic resistance and
genetic relatedness. Additional MRSP isolates as well as the S.
pseudintermedius type strain were sequenced for comparative purposes, and
two isolates similar to S. pseudintermedius yet of undetermined species were
sequenced for identification. All but 2 genomes were able to be assembled into
less than 250 contigs, with all genomes estimated to have near complete length
and CDS content. A total of 120,378 coding sequences were predicted and 838
were found to be associated with resistance to antimicrobials.
GC Content
Strain ID
Contigs
Length
CDS
RNAs
(%)
E140
1
2,769,612
37.4
2750
88
NA45
1
2,841,212
37.3
2811
76
06_3228
1
2,766,566
37.4
2734
77
08_1661
1
2,731,109
37.5
2640
88
NA47
160
2,610,992
37.5
2786
87
NA07
89
2,641,987
37.3
2625
83
NA12
260
2,727,222
37.2
2817
107
LMG22219
54
2,532,112
37.7
2367
87
ATCC49171/
96
2,912,067
37.4
2691
86
DSM20771
NCTC11048/
42
2,842,653
37.4
2737
81
ATCC29663
E15
112
2,746,849
37.5
2486
98
Wood46
44
2,824,597
32.8
2664
75
54
2,694,682
37.4
2570
70
MI 13-1718c
43
2,747,982
37.3
2654
76
06-1066A
50
2,752,197
37.3
2655
74
06-1066B
39
2,528,901
37.6
2346
78
MI 14-243
43
2,726,976
37.3
2598
76
NA157
10
1,232,915
26.5
1175
39
MI 14-3285
24
2,709,785
37.4
2613
74
NA91
41
2,774,474
37.4
2658
81
NA16 Pre
55
2,815,620
37.4
2737
75
NA16 Post
51
2,506,760
37.7
2323
83
117N
20
2,492,699
37.7
2306
71
111N
18
2,627,934
37.5
2483
73
104N
275
2,870,341
37.6
2976
91
NA189
39
2,625,282
37.4
2462
81
NA63
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Table 4 continued.
Strain ID

Contigs

Length

NA77
NA104
NA3
NA36
NA38
NA179
NA180
NA184
NA149
NA144
NA125
NA109
MI 16-2909a
MI 16-2925a
P27B
P50
MI 16-1129A
52-006A
56-021A
B1549
B1553

77
22
93
37
39
34
37
50
36
75
52
53
19
24
46
52
51
46
24
99
65

2,526,388
2,598,667
2,887,757
2,779,784
2,626,861
2,648,782
2,534,249
2,604,494
2,590,820
2,689,443
2,643,586
2,559,916
2,484,103
2,537,562
2,724,944
2,696,881
2,727,320
2,635,079
2,735,112
2,765,460
2,841,072

GC Content
(%)
37.8
37.5
37.1
37.3
37.4
37.4
37.6
37.5
37.5
37.5
37.3
37.6
37.7
37.6
38
37.9
37.8
38.3
38.1
37.2
37.2

CDS

RNAs

2369
2435
2805
2663
2479
2474
2354
2453
2439
2606
2517
2406
2294
2356
2551
2545
2582
2416
2558
3542
2870

76
80
76
79
75
82
77
76
75
81
77
80
73
72
82
93
88
89
83
67
84

Using the major clonal lineage genomes for North America minus the
European-associated ST71 08-1661, a Venn diagram of shared predicted coding
sequences estimates the core genome for S. pseudintermedius from North
America to be roughly 2,111 CDS with anywhere from 110 to 436 unique
accessory genes (Figure 7.)
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Figure 7. Core and Accessory Predicted Coding Sequences among North American
Staphylococcus pseudintermedius isolates.
Coding sequences for 5 representative MRSP isolates were compared using genomewide BLAST with matches >65% homology. Each colored region represents the entire
complement of coding sequences for one genome; overlapping colors represent coding
sequences shared between those genomes. The 2111 coding sequences in the center
of the Venn diagram therefore represent the core genome shared by all S.
pseudintermedius isolates included in the study. The outer single colors show the
number of unique genes in each genome.

Isolates 08-1661, 06-3228, NA45, NA07, NA12 and NA47 were
investigated in detail as they represent major clonal lineages in North America.
To acquire the complete closed genomes for isolates NA45, 08-1661 and 063228, the following data were obtained in addition to optical genome maps; the
total number of high quality reads for strain NA45 were 29,463 (PacBio), 583,182
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(Illumina), 279,674 (Roche) and 4,660,374 (Ion Torrent) resulting in >250-fold
overall coverage. The NA45 genome is 2,841,212bp with a 37.3% GC content,
2665 predicted coding sequences and 78 predicted RNAs. High quality reads for
strain 08-1661 were 456,358 (Illumina), 129,593 (Roche) and 2,578,704 (Ion
Torrent) resulting in >250-fold overall coverage. The 08-1661 genome is
2,731,109bp with a 37.5% GC content, 2610 predicted coding sequences and 87
predicted RNAs. High quality reads for strain 06-3228 were 24,585 (PacBio),
15,886,636 (Illumina), 113,288 (Roche) and 3,864,512 (Ion Torrent) resulting in
>250-fold overall coverage. The 06-3228 genome is 2,766,566bp with a 37.4%
GC content, 2734 predicted coding sequences and 77 predicted RNAs.
Sequencing results for all strains are listed in Table 4.
Resistance Gene and Phage Content
The 08-1661 genome shared 99% identity across 96% coverage of the
published ST71 European isolate E140, with the major differences resulting from
prophage composition (32). All major ST isolate genomes contained the
methicillin resistance gene mecA and the beta-lactamase gene blaZ, as well as
non-identical versions of the aminoglycoside resistance gene aac(6’)-aph(2’’)-Ia,
with the exception of NA45. Isolates 08-1661, 06-3228 and NA45 contain the
aminoglycoside resistance genes aph(3’)-III and ant(6)-Ia. Interestingly, while the
CARD database identifies these two genes as functionally providing resistance to
the aminoglycoside antibiotics generally and two papers provided as references
suggest resistance to the class in general (100, 101), several studies have
shown that aph(3’)-III encodes specific resistance to kanamycin (and others but
not gentamicin) while ant(6)-Ia encodes resistance to streptomycin alone (102,
88). An extensive literature review concluded that of the 3 “aminoglycoside
resistance” genes found in these genomes only aac(6’)-aph(2’’)-Ia has been
proven to confer resistance to the major component of gentamicin antibiotic
solutions in Staphylococcus (102, 88; 103).
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Isolates NA45 and 06-3228 additionally contained genes predicted to
encode resistance to tetracycline, fluoroquinolones, daptomycin, macrolidelincosamide-streptogramins B and fosfomycin. Isolate 08-1661 was predicted to
have the same resistances as 06-3228 with the addition of resistance to
chloramphenicol and elfamycin. Similar to the reference genome E140, isolate
NA07 contains a mutation in the isoleucine-tRNA gene ileS that confers low-level
resistance to the polyketide antibiotic mupirocin (40). To date, only the European
E140 genome has been shown to have this mutation and it has not yet been
investigated experimentally. As mupirocin is an important topical antibiotic used
in both animal and human medicine especially in efforts to combat and
decolonize MRSA, the existence and spread of this mutation is worth future
investigation. A full summary of predicted antibiotic susceptibilities using the
resistance gene finder software ResFinder (80) is presented in Table 5.
Isolate NA45 did not contain the gene aac(6’)-aph(2’’)-Ia and was
manually investigated due to Resfinder and CARD database prediction of
general aminoglycoside resistance despite this missing gene. While NA45
contained the same aminoglycoside resistance genes aph(3’)-III and ant(6)-Ia as
many of the other genomes, it was distinctly lacking the aac(6’)-aph(2’’)-Ia gene.
This gene, present in HKU10, E140, 08-1661, 06-3228, NA12 and NA07 resides
within intact prophages in each of those genomes. Interestingly, the specific
phage sequence containing the aac(6’)-aph(2’’)-Ia gene seems to differ between
most of the isolates, indicating either that the assembly process generated
inaccurate sequence due to large repeats in phage structural genes, or that this
gene is located in different bacteriophage and independently acquired in each
genome.
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Table 5. ResFinder Results of Predicted Antibiotic Susceptibilities for
Major Clonal Lineage Isolates.
The antibiotic resistance gene finding software ResFinder was used to detect genes
predicted to encode resistance to common antibiotics using high level identity to known
Genbank sequences for the dominant clonal lineages of MRSP in North America as well
as the two previously published MSSP.
Isolate
HKU

ED99

E140

81661

Resistance
gene

Identity

Query/HSP

aac(6')-aph(2'')

100

1440/1440

tet(M)

99.9

1920/1920

Aminoglycoside
resistance
Tetracycline resistance

dfrG

100

498/498

Trimethoprim resistance

AB205645

blaZ

100

846/846

Beta-lactam resistance

AJ400722

blaZ

95.74

846/846

AP003139

aph(3')-III

100

795/795

ant(6)-Ia

100

909/909

erm(B)

100

738/738

Beta-lactam resistance
Aminoglycoside
resistance
Aminoglycoside
resistance
Macrolide resistance

blaZ

100

846/846

Beta-lactam resistance

AJ400722

tet(M)

100

1920/1920

Tetracycline resistance

FN433596

aac(6')-aph(2'')

100

1440/1440

aph(3')-III

100

795/795

ant(6)-Ia

100

909/909

erm(B)

99.86

738/738

Aminoglycoside
resistance
Aminoglycoside
resistance
Aminoglycoside
resistance
Macrolide resistance

blaZ

100

846/846

Beta-lactam resistance

AJ400722

mecA

100

2010/2010

Beta-lactam resistance

AB505628

tet(K)

99.6

1380/1251

Tetracycline resistance

U38428

cat(pC221)

97.69

648/648

Phenicol resistance

X02529

blaZ

100

846/846

Beta-lactam resistance

AJ400722

dfrG

99.8

498/498

Trimethoprim resistance

AB205645

tet(K)

99.1

888/892

J01764

aph(3')-III

100

795/795

ant(6)-Ia

99.89

909/909

mecA

100

2010/2010

Tetracycline resistance
Aminoglycoside
resistance
Aminoglycoside
resistance
Beta-lactam resistance
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Phenotype

Accession
no.
M13771
X75073

M26832
AF330699
AF299292

M13771
M26832
AF330699
JN899585

M26832
AF330699
AB505628

Table 5 continued.
Isolate

NA45

63228

NA12

NA07

NA47

Resistance
gene

Identity

Query/HSP

aac(6')-aph(2'')

99.86

1440/1441

erm(B)

99.86

738/738

tet(K)

99.86

1380/1381

aph(3')-III

100

795/795

ant(6)-Ia

99.89

909/909

blaZ

100

846/846

Tetracycline resistance
Aminoglycoside
resistance
Aminoglycoside
resistance
Beta-lactam resistance

mecA

100

2010/2010

Beta-lactam resistance

AB505630

dfrG

99.8

498/499

AB205645

ant(6)-Ia

100

909/909

tet(M)

99.95

1920/1921

aac(6')-aph(2'')

99.93

1440/1441

mecA

99.95

2010/2011

aph(3')-III

100

795/795

blaZ

100

846/846

Trimethoprim resistance
Aminoglycoside
resistance
Tetracycline resistance
Aminoglycoside
resistance
Beta-lactam resistance
Aminoglycoside
resistance
Beta-lactam resistance

lnu(A)

93.02

486/487

Lincosamide resistance

M14039

erm(B)

99.86

738/738

Macrolide resistance

JN899585

lnu(A)

92.95

486/482

M14039

aac(6')-aph(2'')

99.72

1440/1440

tet(M)

100

1920/1920

Lincosamide resistance
Aminoglycoside
resistance
Tetracycline resistance

FN433596

blaZ

100

846/846

Beta-lactam resistance

AJ400722

mecA

99.95

2010/2010

Beta-lactam resistance

AB505630

blaZ

100

846/846

Beta-lactam resistance

AJ400722

lnu(A)

92.13

486/432

Lincosamide resistance

M14039

tet(M)

100

1920/1920

Tetracycline resistance

FN433596

mecA

99.9

2010/2012

AB505630

aac(6')-aph(2'')

100

1440/1440

blaZ

100

846/846

Beta-lactam resistance
Aminoglycoside
resistance
Beta-lactam resistance

mecA

100

2007/2007

Beta-lactam resistance

AB033763
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Phenotype
Aminoglycoside
resistance
Macrolide resistance

Accession
no.
M13771
JN899585
U38428
M26832
AF330699
AJ400722

AF330699
X92947
M13771
AB512767
M26832
AJ400722

M13771

M13771
AJ400722

However, this doesn’t explain why some of these genomes (NA12, NA07,
06-3228) were determined to be susceptible to gentamicin by at least one of the
two testing methods. It is worth noting the ant(6)-Ia gene sequence carried on a
transposon within all major STs contained a deletion mutation relative to the
gene in E140 and other gentamicin-resistant genomes in Genbank. While the
ant(6)-Ia gene has been shown to confer resistance to streptomycin (88, 103), it
has been implicated in general aminoglycoside resistance in multi-resistant
isolates (100, 101). An alignment of the ant(6)-Ia gene within the transposon
between E140 and isolates 08-3228, 08-1661 and NA45 revealed a deletion
contained within the ant(6)-Ia gene which was predicted to truncate the full length
protein product (Figure 8).

Figure 8. Truncated ant(6)-Ia Gene Product in North American Isolates.
A shared transposon in isolates E140, NA45, 08-1661 and 06-3228 contained the
aminoglycoside resistance gene ant(6)-Ia. European Isolate E140 was resistant to
gentamicin using both standardized assays while the other isolates were either
intermediate or susceptible, potentially due to the ant(6)-Ia gene being truncated in these
3 North American isolates.

If this predicted deletion truncates the protein by shifting the reading frame in the
North American isolates, it could result in loss of resistance to streptomycin in
these genomes. As some resistance to gentamicin was determined for 08-1661
and 06-3228, but not NA12, NA07 or NA45, the other aminoglycoside resistance
gene identified (aac(6’)-aph(2’’)-Ia) could be responsible for the few gentamicin42

resistant interpretations in initial testing. Isolates 08-1661 and 06-3228 were
determined to be susceptible to gentamicin using microbroth dilution yet
intermittently resistant using disc diffusion, while NA12 and NA07 were
interpreted as susceptible using both methods. As aac(6’)-aph(2’’)-Ia is supposed
to confer high-level resistance (HLR) it is unclear why any susceptible
interpretations for these isolates exist.
The genome of isolate 08-1661 was sequenced initially using the standard
methodology using overnight growth culture without the addition of antibiotics.
The observation that isolate 08-1661 was initially interpreted as resistant to
chloramphenicol by disc diffusion yet susceptible by microbroth dilution (Vitek)
was investigated by a second round of WGS using the standard overnight growth
but with the addition of 25µg/mL chloramphenicol. The chloramphenicol
acetyltransferase gene CAT was detected identically in both genomes, however,
the WGS data from the culture grown with chloramphenicol resulted in a 10x
increased mean depth of coverage relative to the culture absent selection (Table
6). This indicates that the gene copy number increased upon exposure to
chloramphenicol allowing increased resistance to this compound.

Table 6. Average Depth of Coverage and Percent Reads for 08-1661
Select and Non-Select WGS Data.
Isolate 08-1661 was predicted to be resistant to chloramphenicol through a resistance
gene found on one of the two plasmids discovered in its genome. While it was
interpreted as resistant using disc diffusion, it was not by Vitek. Re-sequencing the
isolate after exposure to chloramphenicol resulted in greater than 3x increase in plasmid
copy number for the chloramphenicol plasmid, as well as an increase in copy number for
the second plasmid encoding resistance to tetracycline, suggesting that increased
antibiotic resistance is mediated by plasmid copy number.
Selection

Total Reads

Negative

2578704

16s Avg.
Depth
919

Positive

456358

242

Negative

2578704

919

4073

1:4.432

Positive

456358

242

3745

1:15.475

CAT Avg. Depth

TetK Avg. Depth

Ratio

1205

1:1.311

1596

1:6.595
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Resistance to lincosamides was predicted through multiple genes in 063228, NA12 and NA07, yet isolate NA12 was interpreted as susceptible to
clindamycin using both disc diffusion as well as microbroth dilution. Clindamycin
is a lincosamide used to determine resistance, generally, to that class of
antibiotics. Some of these lincosamide resistance genes in these genomes are
most similar to genes predicted to encode only resistance to lincomycin (104), a
commonly used antibiotic in veterinary medicine (105); thus, it is possible that
resistance to lincomycin and lincosamides in general is not accurately
represented using clindamycin as a surrogate in susceptibility assays (106).
Bacteriophage and prophage content of the major STs was assessed
using the PHAge Search Tool (99), and results are shown in Table 7.

Table 7. Phage Genome Content Summary as Detected by PHAST.
The software PHAST was used to identify prophage sequence in genomes of the
dominant lineages of MRSP in North America as well as the previously published MSSP.
A total of 40 prophage insertions were identified and were more associated with MRSP
than MSSP. In addition, 1579 genes were located within these insertions and accounted
for a large percentage of the accessory genome for each isolate.
Intact
Total
Total
Genome
Incomplete
Phage
Kb
CDS
ED99
0
0
0
0
HKU101
2
141
154
03
E140
3
4
307
387
NA07
1
1
56
81
NA12
0
2
26
37
NA45
2
6
272
304
NA47
2
3
122
130
63228
3
5
210
255
81661
2
3
195
231

MSSP genomes were found to have fewer overall phage, with the
reference genomes ED99 predicted to contain none (although phage structural
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genes are present indicating significant pseudogenezation), HKU having 3 and
the MRSP genomes averaging 5 each. The lack of intact or incomplete phage
sequence detected in ED99 could be the result of an assembly artifact; as
mentioned in the introduction, phage sequence can be very repetitive and
repetitive DNA sequence is difficult to assemble. Thus, it is possible that phage
sequences exist in ED99 yet were not included in the final assembly. This
hypothesis is supported by the fact that an optical map of ED99 created outside
of the scope of this project showed roughly 50,000bp of DNA to be missing
relative to the published genome sequence. As HKU also represents an MSSP
and has 1 intact prophage and 2 incomplete, comprising ~141,000bp and ~154
genes, it seems reasonable to assume ED99 does have some phage content. As
the MSSP genomes are generally smaller than MRSP genomes and contain less
prophage insertions, it can be generalized that prophage content increases
genome size and is positively associated with successful S. pseudintermedius
clonal lineages.
Isolates NA07 and NA12 belong to closely related ST64 and ST124,
respectively, which makes the observation that they both have 2 phage
potentially meaningful considering the fact that the other MRSPs all have at least
5 phage insertions. Their genomes were assembled de novo independently, yet
when compared using MAUVE they show surprising genome arrangement and
identity of >99%. Results from a core genome phylogenetic analysis using the
software PanSeq (107) show an almost identical relatedness when compared
with the other genomes (Figure 9). Aside from the core SNP genome analysis
and phylogenetic tree providing validation of the MLST-7 typing system (as the
relationships shown are similar to those from eBURST analysis), it also reveals
that the ST71 isolates 08-1661 and E140 have >99% identity and are closely
related, which is to be expected if MLST-7 predicts them to be the same
sequence type. In fact, the majority of genome content variation between the
ST71 isolates 08-1661 and E140, as well as the S. pseudintermedius isolates in
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general, are genes contributed by phage whereas differences in shared genes
result from DNA mutation. Figure 10 shows a whole genome alignment between
E140, 08-1661, 06-3228 and NA45 complete genomes. Each colored block
represents global syntenic regions of DNA colineation, while the large white gaps
in each genome represent prophage insertions not found in at least one
corresponding location in another genome.

Figure 9. PanSeq Phylogenetic Tree of Core Genomes of 9 S. pseudintermedius
Isolates.
Core genomes identified using genome-wide BLAST were concatenated and aligned,
and phylogenies determines using maximum likelihood for dominant lineages of MRSP
in North America. The North American ST71 isolate 08-1661 and European ST71 isolate
E140 were found to have almost identical core genomes.

It is interesting, however, that ST64 and ST124 are >99% identity yet belong to
different STs. Perhaps the 08-1661/E140 relationship and the NA07/NA12
relationship represent the upper and lower limits of MLST-7.
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Figure 10. Mauve Genome Alignment Reveals Alignment Gaps Caused by Prophage
Insertions.
Complete genomes of E140, 08-1661, 06-3228 and NA45 (descending) were aligned
using MAUVE. Colored blocks show highly conserved genomic regions with average
sequence identities represented graphically within. Most of the large unaligned white
gaps resulted from unique prophage insertions.

As with the ST71 isolates E140 and 08-1661, this nearly identical
relationship would be expected if the MLST-7 typing system is accurate in
determining evolutionary genetic relatedness. However, phage content is
determined by horizontal transfer and bacteriophage infection, which theoretically
operates independently of traditional phylogenetic evolution and would not
necessarily correspond to the same relatedness as the core genome. Without
closing the NA07 and NA12 genomes it is impossible to determine their exact
insertion location, but one of the 2 phage shared between them is identical and
the other is unique to each genome. The ability of bacteriophage to infect and
transpose themselves within a genome may be related to other genome content,
such as CRISPR (108), which could explain the reduced phage content in these
ST64 isolates as well as their 50% shared phage sequence. Interestingly, the
shared phage in NA07 and NA12 contains a fosfomycin resistance protein which
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is found in all but 1 of the other major North American genomes and missing from
the European MRSP isolate E140.
Phage content for isolate NA45 appears to be the highest of all sequenced
major STs with 2 intact and 6 incomplete phage contributing ~272,000bp to the
overall genome. The MRSP isolates besides NA45 had 100,000bp to 210,000bp
of their genome attributed to phage content, with multiple fibronectin-binding
proteins being the highest non-structural genes found within complete and
incomplete phage. This supports the commonly held idea that phage contribute
to virulence primarily through assisting with host adaptation and cell binding
(109). Additional common phage-associated genes include the Streptococcal
Superantigen SsaA, organic hydrogen peroxide resistance genes, ion efflux
pumps associated with antibiotic resistance and variations of holins, lysins and
hydrolases which facilitate cell invasion. These are all generally considered to be
virulence factors and additionally support the association of phage content with
virulence when compared with lower phage content of the MSSP isolates ED99
and HKU10.
Genomic location of phage insertions can be determined for isolates with
complete, circular genomes, namely 08-1661, 06-3228, NA45, E140, ED99 and
HKU10. Maps of phage content and insertion locations can be found in Appendix
C: Prophage Genome Insertion Locations. It is interesting to note that while
phage content does not seem to be associated with Sequence Type, it does
seem to be at least loosely correlated to geographic region (North American
versus non-North American). Conversely, phage insertion location appears to be
somewhat conserved across Sequence Types, yet not across geographic
regions. These relationships make sense in light of genome and virulence
concepts. Sequence Type indicates genetic relatedness, which means having
similar DNA sequence. Thus, genomic recognition sites for bacteriophage
insertion being conserved within related genomes is supported by this data.
Individual phage are thought to be host associated and often provide increased
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growth adaptation and success within individual host populations. Thus, the
sharing of phage within geographic regions which, in theory, have unique host
populations (whether human, animal or bacterial) would lead to specific phage
being transferred regionally. If these patterns hold up across more MSSP and
MRSP genomes with known histories, phage content and insertion site could
represent a valuable, untapped resource for determination of virulence and
evolutionary relatedness. Larger studies have not revealed these relationships
prior to this project; however, this is likely due to the fact that genomes are often
not completed (as in a closed, circular genome) and thus location cannot be
determined. The phage themselves contribute significantly to problematic
genome assemblies due to their very high repetitive DNA sequence in structural
genes such as tail proteins. Many genomes that are in fact circular are done so
using a reference genome to span gaps in the assembly. This method was tried
during this study using ED99, E140 and HKU10 as references; actual optical
maps of 08-1661, 06-3228 and NA45 were then aligned to the referenced-closed
genomes and large sections of DNA were missing. In almost all cases, these
missing segments were prophage sequence, often only overlapping the structural
genes at the two edges of the phage without including the internal content. It is
likely that the use of reference genome mapping, lack of verification using optical
or long-read mapping and unfinished multi-contig genomes has prevented this
trend in phage content and location insertion from being detected before.
Plasmid Identification
Extrachromosomal plasmids were presumptively identified in all major ST
isolates except NA45 and E140 using both the manual method described above
as well as the automatic Geneious circularization during assembly setting (See
Section 2.12, Data Assembly and Analysis). Surprisingly, 4 of the 5 isolates with
presumptive plasmids contained at least two, and isolate NA12 is predicted to
have 3. At least 20 additional presumptive plasmids were identified from the
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remaining sequenced isolates. Table 8 shows plasmids predicted to confer
resistance to select antibiotics in isolates selected to represent dominant
lineages in North America; 08-1661, 06-3228, NA07, NA12 and NA47.
Plasmid identification using MiSeq paired end reads did not result in any
high depth of coverage or circular contig assemblies, and was therefore unable
to identify extrachromosomal plasmids. One reason for this is that the common
and conserved origin of replication gene “Rep” is found not only on almost all
small resistance plasmids but also in multiple locations throughout the genome,
including many SCCmec cassettes (110). Analysis of mapping paired reads back
to plasmids- identified using the manual method from single-read assembliesresulted in either low depth of coverage or contig breaks directly tied to the
location of the Rep gene on these plasmids. It is likely that when one read from a
paired read set sits within the Rep gene, it is placed randomly throughout the
genome on any plasmids that match that Rep sequence or even vary slightly in
content. Because the initial placement may be in the incorrect location for the
paired set, the second read will fail to place into the larger assembly or will place
erroneously. This leads to a failure to match other overlapping paired reads to
this hit and results in either a failed/gapped assembly or inaccurate sequence
with very low depth of coverage. Using paired reads as unpaired reads
eliminates this problem by allowing reads falling in and overlapping with Rep
sequence to place accurately into that location without the constraint of a second
read forcing placement a certain distance away.
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Table 8. Plasmids Predicted from WGS Data to Confer Antibiotic Resistance.
Extrachromosomal plasmids were predicted from genome sequence data using manual and automated annotation for isolates
08-1661, 06-3228, NA07, NA12 and NA47. No extrachromosomal elements were identified for isolate NA45. Important genes
are those found in the plasmid sequence related to resistance to antibiotics or disinfectants.
Strain
Sequence
Important
Size (bp)
Structure
Functional Annotation
ID
Type (ST)
Gene
08_1661
71
3785
Inactivating protein
CatA
chloramphenicol resistance
4439
7 domain pump
tetK
tetracycline resistance
06_3228

68

2360
2730

Inactivating protein
Inactivating protein

LinA
fosB

lincomycin resistance
fosfomycin resistance

NA07

124

2653

Inactivating protein

LinA

2745

3 domain pump

QacG

lincomycin resistance
quaternary Ammonium
compound resistance

2653

Inactivating protein

LinA

2742

3 domain pump

QacG

3660

7 domain pump

CcmA

2258

Compound Transporter

Hypothetical
CDS

NA12

NA47

64

56

51

lincomycin resistance
quaternary Ammonium
compound resistance
lantibiotic and multidrug
resistance pump
unknown; completely novel

Large Linear Plasmid in 06-3228
A large extrachromosomal DNA fragment was detected for isolate 063228; it is not easily identified as a bacteriophage (as it lacks necessary phage
structural genes) nor is it similar to any known plasmids. It is 43,416bp long with
42 predicted coding sequences, of which only 7 have predicted functions from
the RAST annotation. The 5’ and 3’ ends have identical yet terminal inverted
repeats, meaning that while they could bind to each other in the same direction,
they could not circularize the sequence (Table 9).

Table 9: Functional Annotations of Linear Element in 06-3228.
Isolate 06-3228 was found to contain a linear, extrachromosomal genetic element not
associated with typical bacteriophage or plasmid genes and validated through WGS
data, optical mapping and gel electrophoresis. It is completely novel and does not match
more than 1% to any known DNA sequence in Genbank and appears to encode
resistance to teicoplanin and an E. coli toxin/antitoxin system ensuring passage to
daughter cells. It may be capable of self-replication and horizontal transfer as it also
contains the cell division protein FtsK along with the DNA partition protein ParA. It
contains the virulence and secretory antigen SsaA traditionally associated with
transposons yet the contig was unable to be placed in the genome.
Annotation
Length Direction
hypothetical protein CDS
960
forward
hypothetical protein CDS
429
forward
hypothetical protein CDS
483
forward
hypothetical protein CDS
837
reverse
hypothetical protein CDS
1,215
reverse
ATP-dependent Clp protease ATP-binding subunit ClpA
1,929
reverse
CDS
hypothetical protein CDS
3,264
reverse
hypothetical protein CDS
288
reverse
hypothetical protein CDS
900
reverse
hypothetical protein CDS
528
forward
replication initiator protein A CDS
1,518
reverse
hypothetical protein CDS
306
reverse
DNA double-strand break repair Rad50 ATPase CDS
2,184
reverse
hypothetical protein CDS
882
reverse
hypothetical protein CDS
2,025
reverse
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Table 9 continued.
Annotation
hypothetical protein CDS
hypothetical protein CDS
hypothetical protein CDS
hypothetical protein CDS
hypothetical protein CDS
hypothetical protein CDS
hypothetical protein CDS
hypothetical protein CDS
Secretory antigen SsaA-like protein transposon-related CDS
hypothetical protein CDS
hypothetical protein CDS
hypothetical protein CDS
hypothetical protein CDS
DNA partition protein ParA CDS
hypothetical protein CDS
hypothetical protein CDS
hypothetical protein CDS
Cell division protein FtsK CDS
hypothetical protein CDS
hypothetical protein CDS
Teicoplanin resistance associated membrane protein TcaA
CDS
hypothetical protein CDS
hypothetical protein CDS
hypothetical protein CDS
MazE antitoxin
MazF toxin
hypothetical protein CDS

Length
576
312
1,002
726
594
672
249
384
1,335
537
594
363
270
813
168
726
375
2,355
666
297

Direction
reverse
reverse
forward
forward
reverse
reverse
reverse
forward
reverse
reverse
reverse
reverse
forward
forward
reverse
reverse
reverse
reverse
reverse
reverse

1,341

reverse

765
177
402
483
429
960

reverse
reverse
forward
reverse
reverse
reverse

A BLASTn and MegaBLAST search resulted in a 78% identity over 1% of
the sequence and 79% identity over 4% of the sequence, respectively, indicating
a unique and novel genetic element. Read mapping the consensus contig
resulted in blunt end drop off in coverage with no overlapping reads, suggesting it
exists freely outside of the chromosome (Figure 11).
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Figure 11. Read Mapping to Genetic Element in 06-3228 Reveals Sharp Decline in
Coverage and No Overlapping Reads.
Isolate 06-3228 contained a large, ~40Kb contig unable to be placed into the de novo
assembly or optical genome map. Mapping original sequencing reads back to this contig
revealed higher than average depth of coverage with blunt terminal ends. No reads were
found to span beyond the edge of the sequence, nor were inverted terminal repeats
present suggesting the element exists independent of the main chromosome yet is not
circular.

In optical mapping data, it is evident as an independent DNA fragment not
found in the chromosomal DNA and at fairly high copy number in a linear format
with an AflII digestion pattern that matches the in silico pattern created using the
contig from the WGS data (Figures 12, 13, 14).
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Figure 12. Circular Plasmid Content in Whole Genome Mapping.
Circular extrachromosomal plasmids were easily identified in multiple isolates using
optical genome mapping and observed in both relaxed and supercoiled formations. This
image is typical for isolates found to contain circular plasmids. The circular structure is
retained after enzymatic cutting because the DNA molecules are electrostatically bound
to the mapping surface.

Figure 13. High Copy Number Linear Element in 06-3228.
In isolate 06-3228 a uniform length DNA fragment was observed at high frequency in
optical mapping raw images. This molecule is estimated to be ~40,000bp and has two
unique cut sites using AflII.
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Figure 14. Molecule AflII Cut Pattern Matches in silico Pattern of Suspect Contig.
The 06-3228 de novo sequencing contig contained two AflII cut sites that matched the
cut site pattern of the high copy number linear element from the optical mapping images,
reinforcing the extrachromosomal and linear properties suggested by the WGS
assembly.

This element is easily distinguished from genomic DNA when extracted using
Qiagen (CAT #: 27104), Invitrogen (CAT #: K210010) and Sigma (CAT #:
PLN10) plasmid extraction kits and visualized using DNA electrophoresis (Figure
15).
Taken together, this element likely represents a novel large, linear
plasmid-like MGE with an unknown function. It does, however, contain the E. coli
associated MazE-MazF toxin-antitoxin module, which functions to ensure the
replication and carry of this element in the cell. The MazF gene encodes an
endoribonuclease toxin that can be neutralized by the MazE antitoxin (111). As
the toxin is more stable than the antitoxin, a dividing daughter cell lacking the
genetic element containing the genes would be unable to produce the antitoxin
and therefore die as a result of the longer life of the toxin after the antitoxin
degrades (111).
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Figure 15. Agarose Gel Electrophoresis of 06-3228 and NA45 Plasmid DNA Extraction.
Lane 1: isolate 06-3228 plasmid extraction resulting in two faint bands, one above the
highest 40Kb marker in the ladder (lane 4) and one approximately equal with it. Lane 2:
genomic DNA extraction of isolate 06-3228 showing a single band just above the 40Kb
ladder marker indicating high molecular weight genomic DNA. Lane 3: plasmid
extraction of isolate NA45 devoid of plasmids in WGS data.

It has not yet been found to date in any Staphylococcal genome and its
function in this role is unknown. Finally, one predicted gene has a functional
annotation from RAST encoding resistance to Teicoplanin, a semisynthetic
glycopeptide antibiotic similar to the last line of defense antibiotic vancomycin
(112). The gene used to annotate this function is TcaA, which encodes a transmembrane protein thought to confer intermediate level resistance to teicoplanin
and vancomycin (112). However, a direct protein BLAST of the S. aureus
reference sequence for TcaA against the “TcaA-like” protein from 06-3228
returns a very poor hit with only 26% identity over 92% of the sequence (Figure
16).
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Figure 16. BLAST Alignment Between Reference TcaA Sequence and TcaA-like CDS
from 06-3228.
The predicted TcaA protein on the linear element in isolate 06-3228 aligned to TcaA
from Staphylococcus aureus using BLASTp. An Except Value of 4e-39 indicates little
chance of non-random alignment, however, 26% protein identity displays remarkable
variation of the protein sequence which may not retain the same function.

The best BLAST result against the non-redundant Genbank protein
database hits to several “hypothetical protein” results at best 64% identity over
100% query coverage. If search constraints are loosened, these proteins align to
the reference TcaA gene at about 54% identity; there are several at this level of
identity that have been deposited with the identifier “TcaA-like protein” and
inferred resistance to teicoplanin without any experimental data. With these
extremely poor results for all of these entries except the good experimental data
for TcaA from S. aureus, it seems possible that many authors have submitted
protein sequence with extremely poor matches to TcaA that are actually
unrelated to that genes function. However, as the top BLAST hit can often be an
extremely poor hit, it frequently happens that authors use the top hit regardless of
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quality when assigning a hypothetical function to their submissions. Therefore,
the role of the 06-3228 protein in resistance to teicoplanin or vancomycin seems
suspect.
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Chapter Three:
comparison of Predicted antibiotic susceptibility genotypes with
in vitro susceptibility test results
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Abstract
Whole genome sequencing was performed on 30 MRSP clinical isolates
and revealed genes predicted to contribute to antibiotic resistance on previously
unknown mobile genetic elements such as plasmids and prophage. Four isolates
with discrepant antibiotic susceptibilities representing dominant clonal lineages in
North America were found to have genes predicted to encode resistance to
antibiotics that they tested susceptible or intermediate for using standard assays.
A novel media-based growth assay was developed to investigate resistance to
these antibiotics beyond the standard time points of 4 and 24 hours.
All isolates predicted genotypically to be resistant to antibiotics not
originally interpreted as resistant to were found to be able to display high level
resistance in the growth assay but only after at least 24 hours adaptation in
selective media. When removed from selection for 24 hours and re-tested using
the same assays, resistance was maintained at the highest observable level
using these methods. Phenotypic resistance observed in the growth assays and
re-testing matched the antibiotic resistance genotype predicted from whole
genome sequencing data for each isolate.
A gene encoding resistance to chloramphenicol was found to be located
on a plasmid that appeared to increase copy number in response to exposure to
chloramphenicol. Resistance to gentamicin was investigated in four isolates, 2 of
which were repeatedly interpreted as susceptible using both assays and 2 of
which were reported either susceptible or intermediate using disc diffusion but
reliably susceptible in microbroth dilution. High level gentamicin resistance was
observed in all 4 isolates after longer than 24 hours initial exposure to the
antibiotic in the growth assay and was maintained 24 hours after removal from
selection using both standard assays. The aac(6’)-aph(2’’)-Ia gene known to
encode high level gentamicin resistance was found in all 4 isolates, so
susceptible determinations using standard assays may not reflect true resistance
profile for this antibiotic.
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While the growth assay used in this study did not correlate directly to
clinical resistance, re-testing using standardized assays suggested the ability to
display high level antibiotic resistance could be inferred from gene content. In
cases where phenotypic assays disagreed, isolates ultimately determined to
have resistance were found to contain resistance genes on mobile genetic
elements.

Introduction
Staphylococcus pseudintermedius is an important pathogen in part due to
the high level of resistance to multiple antibiotics it displays across multiple host
species around the world. Treatment of antibiotic resistant bacterial infections
relies upon both proper identification of the pathogen as well as accurate
characterization of associated resistance to antimicrobials. Two common
antibiotic susceptibility assays used to screen isolates for potentially useful
treatment options are antibiotic disc diffusion and microbroth dilution (113; 114).
Both of these methods measure the ability of the pathogen to grow in the
presence of various concentrations of antibiotic compounds either in agar or
liquid broth. As such, they both represent phenotypic observations of displayed
resistance and do not directly identify underlying genetic mechanisms.
Phenotypic assays measure the ability of the bacteria to survive and/or grow in
the presence of the antibiotics over time; they do not indicate the underlying
mechanism providing this characteristic. With these assays, there is a risk that
clinically relevant resistance could exist, but not be detected under growth or
exposure conditions being provided in the test (115, 116). Conversely, it is
possible for an organism to have a gene known to provide antibiotic resistance in
certain circumstances but the resistance is not high enough to overcome the
concentration of antibiotics that could be used in a clinical setting.
Methods have been developed to use genetics to predict antibiotic
resistance by searching for antibiotic resistance genes and/or mutations and
creating assays to detect them (90, 77, 76). However, one limitation of using
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genetic markers to predict, not determine, antibiotic resistance; simply having a
gene that can provide resistance does not necessarily mean that it will, at least at
a clinically relevant level (115, 89). Researchers have discovered bacteria
containing genes for resistance to an antibiotic or class of antibiotics without
showing phenotypic resistance (116, 89; 90, 117). This could result from one of
many possible reasons, the first of which being that these genes may play
different roles in different organisms facilitating their spread but not necessarily
the resistance characteristic.
Clinical isolates of S. pseudintermedius were sequenced using multiple
whole genome sequencing technologies. Several antibiotic resistances were
predicted from the results of genome sequencing and functional annotation of
hypothetical coding sequences in all S. pseudintermedius isolates sequenced.
While many of the genes identified during WGS match to the ASPs from their
initial testing results, there were disagreements in specific antibiotic resistances
as well as disagreements between the two testing methods- disc diffusion and
Vitek microbroth dilution (86; 114).
Isolate 08-1661 represents a sequence type (ST71) commonly associated
with European MRSP yet is also a major clonal lineage in North America (75,
manuscript in preparation). Two plasmids were predicted to exist
extrachromosomally in isolate 08-1661, both of which encode antibiotic
resistance determinants. Plasmid 08-1661B encodes chloramphenicol
acetyltransferase, an inactivating enzyme with no previous association with
Staphylococcus pseudintermedius (Figure 18). While the isolate was determined
to be resistant to chloramphenicol using disc diffusion, it was interpreted as
susceptible using the Vitek according to the MIC set for S. aureus (CLSI M100S18).
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Figure 17. Plasmid 08-1661B.
Plasmid 08-1661B contains four predicted coding sequences, one of which is
chloramphenicol acetyltransferase identical to that found in S. aureus plasmids.
However, the rest of the plasmid sequence is completely novel with no hits to any known
sequence other than the required RepC replication initiation factor. Two additional
recombination enzymes are co-located on this plasmid which may be capable of
independent movement between isolates.

All major lineage isolates except NA45 have the aac(6’)-aph(2’’)-Ia
aminoglycoside resistance gene, however, 08-1661 and 06-3228 were
determined to be intermediate to gentamicin by disc diffusion and susceptible
using the approved Vitek card. Isolates NA07 and NA12 were determined as
susceptible using both assays. The aac(6’)-aph(2’’)-Ia gene known to encode
high level gentamicin resistance was found in all 4 isolates located on distinct
prophage within each genome.
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MRSP from North America characterized by both assays occasionally
display discrepant results between the two testing methods. One difference
between the assay methods is the time point at which the results are read; 24
hours for disc diffusion and as short as 4 hours for microbroth dilution. As mobile
genetic elements have been known to contribute variable degrees of antibiotic
resistance, it is possible these elements play a role in producing these
discrepancies.
While genotypic assays can predict antibiotic susceptibility profiles for
bacterial isolates, they can only infer the possibility of resistance. Phenotypic
assays have been correlated to animal and human studies for validation that
observed resistance phenotypes are clinically relevant. Genome sequencing of
30 MRSP and 6 MSSP revealed that horizontal transfer of mobile genetic
elements in S. pseudintermedius is likely more frequent than previously
suspected. If antibiotic resistance is mediated by genes carried on mobile genetic
elements and can vary phenotypic detection time points past what are commonly
used in standard assays, it would suggest that the most accurate determination
of antibiotic resistance for a given bacterial isolate may be a combination of
phenotypic and genotypic testing. Furthermore, the role of mobile genetic
elements in antibiotic resistance appears to be important.
Due to the significant discrepancies in calling antibiotic resistance to
chloramphenicol, gentamicin and lincosamides, a novel in vitro testing method
was developed to determine what level of resistance each isolate had to these
antibiotics, and if any level of resistance was seen they would be re-tested using
the standard clinically accepted assays. The plasmids and genes predicted to
code for antibiotic resistance being tested using the growth assay were screened
for using genomic and plasmid DNA extraction as well as PCR amplification.
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Materials and Methods
Standard Antibiotic Susceptibility Testing
Initial antibiotic susceptibility testing was performed according to
standardized guidelines outlined in the Clinical and Laboratory Standards
Institute 2008 informational supplement M100-S18. Minimum inhibitory
concentrations (MICs) were determined by susceptibility testing using the Vitek 2
automated antimicrobial testing system (BioMerieux, Durham, NC) according to
the manufacturer’s protocol. MICs for chloramphenicol have not been
standardized for S. pseudintermedius. Vitek cards AST-GP67 or the newer ASTGP69 was used to test S. pseudintermedius isolates; a representative output with
isolate NA45 is shown in Figure 19 with disc diffusion results recorded manually
for all antibiotics tested.
Initial ASPs were determined via direct plating and dilution in saline to 0.5
McFarland per standard protocol (For disc diffusion, purified isolates were plated
onto Mueller-Hinton agar plates (Thermo Scientific, CAT #: R04050) impregnated
with antibiotic discs and incubated at 35°C for 24 hours. Zone sizes were
determined manually, with the “edge” of the zone being the closest colony or
streak in the entire zone to the disc (Figure 20).
Vitek testing was performed per manufacturer’s protocol; briefly, purified
isolates were diluted in sterile saline and provided as a reservoir for the machine
which automatically inoculates small wells with varying concentrations of
antibiotics, with results coming back as soon as 4 hours later.
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Figure 18. Vitek MICs and Disc Diffusion Results for Isolate NA45.
A representative antibiotic susceptibility profile containing information on disc diffusion
zone sizes and Vitek MICs. Isolate NA45 displayed resistance using disc diffusion to
cefoxitin, oxacillin and ampicillin which are in agreement with the MIC data.
Antimicrobials tested using the Vitek but not disc diffusion are left blank for the Diameter
column, whereas antimicrobials tested using disc diffusion are written in by hand either
next to their Vitek result or outside for those not found on the Vitek card.
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Figure 19. Example of Disc Diffusion Testing with 6mm Zone Size and 14mm Zone Size.
Disc diffusion measures the ability of an antibiotic-impregnated paper disc to inhibit
growth of a lawn of bacteria. This representative image shows an isolate highly resistant
to the antibiotic on the left with the minimum possible zone size of 6mm (the diameter of
the disc), and a 12mm zone with the antibiotic on the right displaying a zone of inhibition.

In vitro Broth Dilution Testing of Antibiotic Resistance
A novel growth assay was developed induce or select antibiotic
resistances that were predicted by genotype but not observed phenotypically.
Experiments were carried out in 10mL conical polystyrene culture test tubes with
caps using both tryptic soy broth (TSB)(Sigma, CAT #: 43592) and the nutrient
rich Antibiotic Broth (Sigma, CAT #: 70184) to examine media-driven differences
in growth and resistance. Chloramphenicol (Sigma, CAT #: C3175) dissolved in
100% ethanol, gentamicin (VetOne Cat #: 510209, injectable) and lincomycin
(Bimeda, CAT #: 1LIN019, injectable) were used for testing antibiotic resistance.
Isolates 06-3228, 08-1661, NA07 and NA12 were obtained from the
UTCVM Bacteriology Laboratory on a trypticase soy blood agar (BA) plate (BD,
CAT # 221261). A single colony was picked for each isolate using a sterile 5µL
loop and used to inoculate 3mL TSB from the glycerol stock, with overnight
incubation and shaking at 210rpm and 37°C. From these initial cultures, 10µL
was used to inoculate 3mL fresh media with select antibiotics based on predicted
resistances specific for each isolate. For chloramphenicol, gentamicin and
lincomycin the initial concentration was 25µg/mL; subsequent increases were
contingent upon successful growth to log phase within 96 hours in the current
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concentration and were increased in increments of 25µg/mL. Time points at
which growth occurred in each concentration were recorded and maximum
growth was defined by the maximum concentration at which no growth was
observed for 96 hours. Each antibiotic containing growth assay was performed in
duplicate and replicated three times.
Negative controls were used to confirm the potency and concentrations of
the antibiotics used. Negative control strains were NA45 for chloramphenicol and
lincomycin, and NA47 for gentamicin as they were phenotypically susceptible
and the genomes were not predicted to contain resistance genes for these
antibiotics. Antibiotic stability was tested using 15µg/mL of each antibiotic in 3mL
TSB with growth recorded daily for 5 days for the negative control isolates. All
growth experiments were carried out in duplicate and replicated 3 times using
new inoculum from the glycerol stock. BA plates containing antibiotics were used
to confirm antibiotic resistance as well as allowing individual colonies to be
picked for further experimentation. Isolates able to grow past an optical density
(OD) of 0.5 in >100µg/mL of each antibiotic in <24 hours µg/mL were considered
resistant. µg/mL Resistant isolates were plated onto Antibiotic Agar No. 1
(Sigma, CAT #: 70181) plates containing 50µg/mL of each antibiotic.
The <24 hour time point for growth in cultures to be considered resistant
while the negative control does not grow >48 hours post inoculation exceeds
standard testing times (51; 114). The MIC90 of these antibiotics in
Staphylococcus species are generally considered >25µg/mL-32µg/mL (42; 88;
105; 118), therefore growth at or above 100µg/mL was used to ensure the best
chance the MIC has been met or exceeded.
Antibiotic Susceptibility Testing Following Growth in Antibiotic-containing
Broth
Isolates 08-1661, 06-3228, NA45, NA47, NA12 and NA07 were grown in
Antibiotic Broth No. 1 (Sigma, CAT #: 70181) without selection overnight from
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glycerol stock as described and plated directly onto non-selective BA plates. At
24 hours, colonies were picked from these plates were tested as per the
standard disc diffusion and Vitek protocols described above. These experiments
were labeled as media (negative) and plate (negative) controls as they were not
subjected to selection in either the growth assay or the subsequent BA plate.
Isolates 08-1661, 06-3228, NA12 and NA07 were grown in selective
Antibiotic Broth No. 1 overnight and plated directly onto non-selective BA plates.
Selection with chloramphenicol at 50µg/mL was used for isolate 08-1661,
gentamicin at 100µg/mL for 06-3228, NA12 and NA07, and 100µg/mL lincomycin
for all 4 isolates. At 24 hours, colonies were picked from these plates per the
standard disc diffusion and Vitek protocols described above and re-tested. These
were labeled as media (positive) and plate (negative) samples as they were
grown in selection in the growth assay but on BA plates without selection prior to
retesting. NA47 was used as a negative control in this experiment and was
media (negative) and plate (negative).
Isolates 08-1661, 06-3228, NA12 and NA07 were grown in selective
Antibiotic Broth No. 1 overnight, washed and diluted to 0.5 McFarland with nonselective broth. Cultures were then plated onto Mueller-Hinton agar plates for
disc diffusion and subjected to testing on the Vitek 2. Selection with
chloramphenicol at 50µg/mL was used for isolate 08-1661, gentamicin at
100µg/mL for 06-3228, NA12 and NA07, and 100µg/mL lincomycin for all 4
isolates. These were labeled as media (positive) samples as they were grown in
selection during the growth assay and re-tested directly. NA47 was used as a
negative control in this experiment but was media (negative).
Presence of Genes and Plasmids
The WGS data and assemblies revealed potential plasmid sequences and
genes both in the genome as well as on plasmids that may confer antibiotic
resistance. To confirm the presence of these plasmids and genes, genomic DNA
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extraction, plasmid DNA extraction and PCR gene amplification were performed
in combination with visualization of DNA and products via electrophoresis and
fluorescent dye. Primers used for amplifying full length plasmids are listed in
Table 10. Primers used to amplify individual genes are in Table 11. Primers used
to Screen for linear element in 06-3228 are in Table 12. Primers and probes for
RT_PCR are in Table 13.
RT-PCR was carried out on the CAT gene as it resides on a plasmid and
was shown to have increased copy number from WGS data when grown in
selection. Isolate 08-1661 was grown in parallel in either no selection or in
150µg/mL chloramphenicol to log phase growth, and DNA was extracted using
the Epicentre® MasterPure Gram Positive DNA extraction Kit (CAT #:
MGP04100, www.epibio.com). Primers and a probe were based upon the
consensus sequence from 08-1661 WGS data, which was identical for all rounds
of sequencing. Primers and a probe for the 16s sequence were used for
comparison of copy number, although it should be noted that there are multiple
copies (6) of the 16s sequence per genome.

Results
Observed Antibiotic Resistance
Isolates 08-1661, 06-3228, NA12 and NA07 recovered from antibiotic
containing broth and plates displayed increased antibiotic resistance when retested (Table 14).
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Table 10. Primers for Plasmid Amplification.
Target
ID/Primer
Name
08 CAT
plasmid
08 TetK
plasmid
06 LinA
plasmid
06 FosB
plasmid
NA12 EmrE
plasmid
NA12 EtBr
plasmid

Origin
Strain

Length

Tm

08_1661

3785

55/59

AAATCCGGATCCTGGTTGTTATAC

TTTTTTCCTAGGTGGTTGCTGGTGTT

08_1661

4439

59/57

AAATTTGGATCCCTGCGAGGCTTAA

TTGGGGCCTAGGTATTAACGACT

06_3228

2360

54

AAATTCGGATCCCAAATATGAGC

TTTTGGCCTAGGAAGAGCTTAT

06_3228

2730

55/54

AAACCCGGATCCATACAATGAAT

TTTTGGCCTAGGCAATTTTCAG

NA12

2742

54

AAATTCGGATCCTAAGTGTCTAGC

TTTTGGCCTAGGTACATTACTAGG

NA12

2700

55

ACGTACAGTAATAACACTTG

GACAGACGAAACAAATGA

F Primer

R Primer
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Table 11. Primers for Amplification of Individual Resistance Genes.
Target ID/Primer
Name

Origin
Strain

Length

Tm

F Primer

NA12 ABC

NA12

486

57

CAGTCATGTATTCTGGTAAATAA

08chl

08_1661

959

52/53 ATGGTGGTTGTTATACGTTCAT

CCAGTCGATTTAACGGACTTAAT

08tetK

08_1661

723

55/54 AGTCGTTAATACGTGTGCTCTG

CATTCCGTTTATGCTTGGTTTGT

06LinA

06_3228

735

54

CACATCAAGGCTTTAAGGGTAAC CGTTGAGAAGAACCCTTAACTAAAC

NA07 LinA

NA07

722

55

GTGCGTTGAGAAGAACCCTTA

GCCGGCAATAGTTACCCTTAT

general
AAC6_APH2

Generic

337

57

CACAAATGTTAAGGCAATGA

TTGTTCTTCTTCTGACATAGTA

NA12 EmrE

NA12

265

48/47 TCTCAATTGCAACAGAAATA
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R Primer
CTCAAATGGAAGAAATAGTGG

CCTATAACAATTAAGCCAATAGA

Table 12. Primers for Amplifying Targets in 06-3228 Linear Element.
Target
ID/Primer
Name
06
40Kb/TCA

Origin
Strain

Length

Tm

06_3228

673

55

GTTTCAGGATATACCTTCCGGAC

06
40Kb/FtsK

06_3228

676

54

GGATATTTACAGATTTACCTGAACCAG GAATGGTGAAGAACACGATGAAC

06
40Kb/BPR

06_3228

489

54

TTATTGACTTTGTGCATACCCTTAC

CTATATGACTGTTAGCGAAGGACA

06
40Kb/MazE

06_3228

323

54

TACTAACATGTGGTGTGTGAGG

TAGATCCCACTCGAGGTAAAGA

06
40Kb/virb4

06_3228

954

F Primer

55/54 TTTGTTTAAGCTCGGAGGACA
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R Primer
AGATAAGCCTTTAAGTGGCTCAG

TAGGATAAGTGTTAGGAGGAGGG

Table 13. Primers and Probes for RT-PCR Assays.
Target ID/
Origin
Primer
Length Tm
F Primer
R Primer
Probe
Strain
Name
AAC6_APH2/
CACCAGAAATTT CGCAACAATATA
Generic
160
56
TTTAAGACAAATGCACGGTTTAGA
AA6AP2
ATTCTACTATG
TACTCTTCTA
08AGGATTTAACTT GGATATGAAATT
08CAT
120
57
CACTATTAATTCCTGTTCTAAACACT
1661
ATCCCAATAAC
TATCCCTCTTT
AGAGGGTTTCA TGTTAATACTAA
NA12EmrE
NA12
142
57
TACACTACTTTCGTTTGGAATTTG
CAAAGTTAT
TCCTAGACCTG
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Table 14. Resistance to Antibiotics in Growth Experiments and Re-Testing.
Isolates 08-1661, 06-3228, NA12 and NA07 were grown in media containing antibiotics.
08-1661 revealed resistance to chloramphenicol and all isolates revealed resistance to
gentamicin but both phenotypes were delayed beyond the typical 24 hour time point.
When re-tested using standard assays they demonstrated resistance despite removal
from selection for 24 hours prior to re-testing.
Nonselective
disc
diffusion

Nonselectiv
e Vitek
2

Selective disc
diffusion

Selectiv
e Vitek 2

Strain

Drug

Media
Growth

81661

Chloramphenicol

R- delayed

R (9mm)

R

R (6mm)

R

81661

Gentamicin

R-delayed

I (15mm)

I

R (6mm)

R

81661

*Lincomycin/
Clindamycin

R

R

R

R

R

06-3228

Chloramphenicol

S

S

S

S

S

06-3228

Gentamicin

R- delayed

S (17.5mm)

I

R (6mm)

R

06-3228

*Lincomycin/
Clindamycin

R

R (6mm)

R

R (6mm)

R

NA12

Chloramphenicol

S

S

S

S

S

NA12

Gentamicin

R-delayed

I (13mm)

I

R (6mm)

R

NA12

*Lincomycin/
Clindamycin

R (Lin)

S (21.5)

S

S (22mm)

S

NA07

Chloramphenicol

S

S

S

S

S

NA07

Gentamicin

R- delayed

S (16mm)

S

R (6mm)

R

NA07

*Lincomycin/
Clindamycin

R

R (6mm)

R

R (6mm)

R

Resistance in media was not readily observed at 24 hours in chloramphenicol or
gentamicin growth. Isolate 08-1661 was able to grow to log phase in 25µg/mL
chloramphenicol between 24-48 hours, with no observed growth during the first
24 hours post inoculation. Additionally, 08-1661 was able to grow in gentamicin
25µg/mL between 20-34 hours post inoculation. Upon reaching log phase growth
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in each level of concentration, the media was used to inoculate new subcultures
at the same concentration and grow to log phase within 24 hours. At this point,
the next level of concentration was inoculated with the 24 hour growth. Isolate
08-1661 was able to grow within 24 hours to log phase at each concentration
above 100µg/mL chloramphenicol without needing additional inoculations. In
gentamicin, upon an initial delay of 24-48 hours at 25µg/mL gentamicin, no
further delay was observed at each increasing level. Maximum concentrations
this isolate was able to grow in upon successive increases in concentration were
250µg/mL for chloramphenicol and 200µg/mL for gentamicin. An example of
growth at 72 hours is shown in Figure 32.

Figure 20. Selective Media Cultures of Isolate 08-1661 in 100µg/mL Chloramphenicol at
24, 48 and 72 Hours.
Isolate 08-1661 in a chloramphenicol growth assay is shown as a representative
example of 24, 48 and 72 hour growth experiments. Each isolate with each
concentration was replicated at least 5 times and often displayed variable and
inconsistent initial growth time points as measured by optical density exceeding 0.5.
Time points in 24 hour increments were used to account for this variability which is likely
due to a heterologous population of inoculating cells.

Upon re-testing chloramphenicol and gentamicin growth cultures of isolate
08-1661 with the standard disc diffusion and microbroth dilution using the media
(negative) and plate (negative) method described above, resistant interpretations
were observed for both methods with chloramphenicol while intermediate
resistance was observed for gentamicin. Upon re-testing chloramphenicol and
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gentamicin growth cultures of isolate 08-1661 with the standard disc diffusion
and microbroth dilution using the media (positive) and plate (negative) method
described above, resistant interpretations were observed for both methods with
both antibiotics (Table 14). Interestingly, when isolate 08-1661 was grown in high
(>100µg/mL) levels of chloramphenicol, resistance to gentamicin decreased,
giving a susceptible call, whereas when grown in 100µg/mL gentamicin
resistance to both antibiotics increased.
Isolate 08-1661 displayed increased susceptibility to gentamicin in the disc
diffusion assay when selectively grown in chloramphenicol (Figure 31). While the
zone size still resulted in a resistant determination the zone was consistently
larger during the growth assay testing with chloramphenicol. This was not
observed when grown in the presence of gentamicin.

Figure 21. Isolate 08-1661 Grown in Chloramphenicol Displays Reduced Resistance to
Gentamicin as Determined by Increased Zone Size in Disc Diffusion Assay.
Isolate 08-1661 was subjected to exposure to chloramphenicol in the growth assay,
ultimately increasing its phenotypic resistance as demonstrated by reduced zone of
inhibition in disc diffusion assays. Conversely, growth in chloramphenicol led to an
increased zone size and reduced resistance to gentamicin, potentially through
competitive gene expression.
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Isolate 06-3228 reached log phase growth in 25µg/mL gentamicin
between 48-72 hours post-inoculation, with no observed growth for the first 24
hours. Upon reaching log phase growth in each level of concentration, the media
was used to inoculate new subcultures at the same concentration and grow to
log phase within 24 hours. At this point, the next level of concentration was
inoculated with the 24 hour growth. Isolate 06-3228 displayed a delayed growth
phenotype at each level of gentamicin exposure, taking between 48-72 hours at
each concentration to adapt. Once adapted, 24 hour growth in a new inoculum at
the previous concentration was observed. The maximum gentamicin
concentration isolate 06-3228 was able to grow in was 200µg/mL. Upon retesting gentamicin growth cultures of isolate 06-3228 with the standard disc
diffusion and microbroth dilution using the media (negative) and plate (negative)
method described above, disc diffusion determined gentamicin as susceptible
whereas microbroth dilution determined intermediate level resistance. Upon retesting gentamicin growth cultures of isolate 06-3228 using the media (positive)
and plate (negative) method described above, resistant interpretations were
observed for both methods (Table 14).
Isolate NA12 reached log phase growth in 25µg/mL gentamicin between
24-48 hours post-inoculation, with no observed growth for the first 24 hours.
Upon reaching log phase growth in each level of concentration, the media was
used to inoculate new subcultures at the same concentration and grow to log
phase within 24 hours. At this point, the next level of concentration was
inoculated with the 24 hour growth. Isolate NA12 displayed a delayed growth
phenotype at concentrations of 25µg/mL and 50µg/mL, taking between 24-48
hours at each concentration to adapt. Once adapted, 24 hour growth in a new
inoculum at the previous concentration was observed. The maximum gentamicin
concentration isolate NA12 was able to grow in was 150µg/mL. Upon re-testing
gentamicin growth cultures of isolate NA12 with the standard disc diffusion and
microbroth dilution using the media (negative) and plate (negative) method
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described above, both assays interpreted as intermediate level resistance. Upon
re-testing gentamicin growth cultures of isolate NA12 using the media (positive)
and plate (negative) method described above, resistant interpretations were
observed for both methods (Table 14). While all 4 isolates were grown in
lincomycin selection using this approach, NA12 was the only isolate that was
interpreted as susceptible in the standardized assays. The standardized assays
used clindamycin to approximate resistance to lincosamides, whereas the media
culture used lincomycin.
Isolate NA07 reached log phase growth in 25µg/mL gentamicin between
48-72 hours post-inoculation, with no observed growth for the first 24 hours.
Upon reaching log phase growth in each level of concentration, the media was
used to inoculate new subcultures at the same concentration and grow to log
phase within 24 hours. At this point, the next level of concentration was
inoculated with the 24 hour growth. Isolate NA07 displayed a delayed growth
phenotype at all levels of concentration up to 100µg/mL, taking between 24-48
hours at each concentration to adapt. Once adapted, 24 hour growth in a new
inoculum at the previous concentration was observed. The maximum gentamicin
concentration isolate NA07 was able to grow in was 150µg/mL. Upon re-testing
gentamicin growth cultures of isolate NA07 with the standard disc diffusion and
microbroth dilution using the media (negative) and plate (negative) method
described above, both assays called it gentamicin susceptible. Upon re-testing
gentamicin growth cultures of isolate NA07 using the media (positive) and plate
(negative) method described above, resistant interpretations were observed for
both methods (Table 14).
Isolates 08-1661, 06-3228, NA45 and NA47 were also grown in selective
media and tested directly using each assay without using a non-selective BA
plate. Images of disc diffusion plates were taken as 08-1661 and 06-3228 failed
to grow sufficiently on both the Mueller-Hinton plates (Figures 22 and 23) as well
as in the Vitek control well. Isolates NA45 and NA47 grew normally (Figures 24
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and 25). The Vitek instrument did indicate growth of 08-1661 and 06-3228 in
non-control, antibiotic containing wells. The Mueller-Hinton plates appeared to
have irregular growth and colony size distribution.

Figure 22. Mueller-Hinton Plate of Direct Plating 08-1661 from Selective Media.
Isolate 08-1661 failed to grow to a readable concentration by 24 hours on Mueller-Hinton
plates when taken directly from media containing high concentrations of chloramphenicol
in the growth assay. Two large colonies were observed (one near the chloramphenicol
disc) among a lawn of small colony variants. Multiple experimental replicates produced
similar results of a heterologous population with few large colonies. Cultures grown in
the growth assay without selection produced normal Mueller-Hinton plate results.
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Figure 23. Mueller-Hinton Plate of Direct Plating 06-3228 from Selective Media.
Isolate 08-1661 failed to grow to a readable concentration by 24 hours on Mueller-Hinton
plates when taken directly from media containing high concentrations of gentamicin in
the growth assay. Eight large colonies were observed among a lawn of small colony
variants. Multiple experimental replicates produced similar results of a heterologous
population with few large colonies. Cultures grown in the growth assay without selection
produced normal Mueller-Hinton plate results.
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Figure 24. Mueller-Hinton Plate of Direct Plating NA45 from Non-Selective Media.
Isolate NA45 was able to grow a uniform, visible lawn at 24 hours on Mueller-Hinton for
disc diffusion testing when taken directly from non-selective media in the growth assay.

83

Figure 25. Mueller-Hinton Plate of Direct Plating NA47 from Non-Selective Media.
Isolate NA47 was able to grow a uniform, visible lawn at 24 hours on Mueller-Hinton for
disc diffusion testing when taken directly from non-selective media in the growth assay.

The Mueller-Hinton plates of 06-3228 inoculated directly from selective
media displayed a large colony and small colony variant (Figure 26.).
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Figure 26. Individual Sparse Large Colonies Observed on Mueller-Hinton Plates from
Selective Cultures of 06-3228.
Large and small colony variants were observed on Mueller-Hinton plates during disc
diffusion assays re-testing isolates 08-1661 and 06-3228 after increasing antibiotic
resistance in vitro. Subculture of these colonies revealed two colony variants, likely small
colony variants hidden by the large on this original plate.

One colony from the large colony variant shown in Figure 21 was picked
from the 06-3228 Mueller-Hinton plate and plated onto non-select Antibiotic Agar
No. 1, resulting in two extreme colony variant types- very large and very small
(Figure 27).
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Figure 27. Colony Morphotypes of 06-3228 Colony Picked from Mueller-Hinton Plate
Subcultured onto Non-Selective Agar.
The large colonies observed on Mueller-Hinton plates after selective growth assays for
isolates 06-3228 and 08-1661 grew two clear subpopulations of cells when further
subcultured without selection. This likely represents a heterologous population in the
large colony picked being unable to prevent transfer of small colony variants.

A streak was taken from the lawn of the same Mueller-Hinton plate and
subsequently re-plated, revealing a small but relatively uniform colony formation
(Figure 28).
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Figure 28. Subculture of 06-3228 Lawn Picked from Mueller-Hinton Plate on NonSelective Agar.
Small colony variants on Mueller-Hinton plates after selection in the growth assay
subcultured into a mixed but mostly small colony variants for both 08-1661 and 06-3228.
While all colonies observed are considered small for 24 hour growth, the variability in
size observed is repeatable and likely represents small variability due to the inability to
pick individual small colonies from the original plate. No large colony variants are
observed after subculture of more than 5 small streaks.

Presence of Genes and Plasmids
Not all primer sets for amplification of full length plasmids and genes were
successful. To verify the presence of the large linear element found in isolate 063228, 5 primer sets were developed using the sequences of 5 CDS found in the
sequence that do not match to any hit in any S. pseudintermedius in Genbank.
Standard PCR cycling conditions with a 55°C annealing temperature at 40 cycles
resulted in successful, single band amplification which was verified by
sequencing the PCR product of each reaction (Figure 26).
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Figure 29. Amplification of 5 Genes Found on Linear Element in 06-3228.
The linear genetic element in isolate 06-3228 contained 5 predicted coding sequences
matching to genes in other species, yet with no sequence above 45% identity in any S.
pseudintermedius sequence in Genbank. PCR was used to verify the presence of these
sequences in this MRSP isolate. Five genes unique to the linear element sequence are
flanked by DNA ladders on the right and left.

The plasmid-borne LinA gene identical in 06-3228, NA07 and NA12
amplified from 06-3228 as expected, as well as the functionally annotated tetK
gene and CAT gene from 08-1661 (Figure 27).
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Figure 30. 1Kb Extend DNA Ladder with 06-3228 LinA, 08-1661 tetK and 08-1661 CAT
Amplicons.
Primers were designed to amplify the plasmid-borne LinA gene found in 06-3228, NA12
and NA07 (lane 2), and the plasmid-borne CAT and tetK genes in 08-1661 (lanes 3, 4).
DNA ladders are in lanes 1 and 5 for sizing estimate.

Purified plasmids were difficult to visualize on agarose gels, and even
when grown in selection visualization was only achieved in some replicates
despite significant modifications to the protocol for lysis times, starting
concentration and elution techniques (Figure 28).
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Figure 31. Visualization of DNA using Whole DNA Precipitation.
Total DNA precipitation and plasmid extraction followed by gel electrophoresis was
performed on isolates NA12 and NA07. Lanes 2 and 3 show the lack of plasmids in
NA12 and NA07 using the plasmid extraction kits. Total DNA precipitation for the same
cultures were run in Lane 4 and 5. Lane 4 shows NA07 with genomic DNA and
potentially two light plasmid bands; lane 5 is NA12 genomic DNA with potentially 3 light
plasmid bands.

The tetK-carrying plasmid from isolate 08-1661, the chloramphenicol
resistance plasmid from 08-1661 and the LinA-carrying plasmid from isolate 063228 were amplified using extended PCR extension times of 5 minutes (Figure
29).

Figure 32. Plasmids Amplified using Full Length Primer Sets.
PCR amplification was performed using inverted primer sets for 5 plasmids from isolates
08-1661 (tetK, CAT), NA12 (LinA), NA07 (LinA) and 06-3228 (LinA). Lane 1 is ~4439bp
tetK plasmid from isolate 08-1661; lane 2 is CAT plasmid from isolate 08-1661; lane 5 is
LinA plasmid from isolate 06-3228. NA12 and NA07 were PCR positive for the plasmid
genes but unable to amplify full length plasmids. Primers were designed inverted facing
outwards, requiring a circular construct for amplification and verifying circularization.
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Real-Time Quantitative PCR was performed as described on the CAT
gene sequence relative to 16s sequence to determine if there was an increase in
gene copy number, which would reflect a likely increase in plasmid copy number
per cell. Isolate 08-1661 was grown in parallel in non-selective media and
150µg/mL chloramphenicol, and each sample was run with a 16s control primer
set. The copy number of the sample grown in selection (CT= 21.28) was higher
than its 16s control (CT=26.52) while the non-selective sample had almost
identical CT values for both (CT= 13.99; CT=14.50).

Discussion
Antibiotic resistance was predicted from genome sequencing for several
sequenced isolates, and 4 were selected for individual investigation. Isolate 081661 was tested with chloramphenicol and gentamicin and all isolates were
tested with gentamicin and lincomycin. These isolates were selected because
one or both of the initial standard assays- disc diffusion or microbroth dilutionconflicted either with each other or with the predicted resistance from the
genome sequence data. Additionally, the chloramphenicol and lincomycin
resistance genes were predicted to be located on extrachromosomal plasmids,
while the gentamicin genes of interest were located in transposons or prophage.
The ability of plasmids and repetitive genomic elements such as phage and
transposons to have variable copy number combined with the conflicting
susceptibility interpretations suggested they may be influencing resistance
profiles. A complete table showing initial susceptibility determinations, genome
predictions, media growth and re-testing can be found in Table 15.
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Table 15. Initial Susceptibility Testing, Genome Sequence Prediction, Media Growth and Re-Testing of 08-1661, 06-3228, NA12
and NA07. “NEG” refers to culture without antibiotics while “POS” refers to growth in antibiotics.
Antibiotic

Initial
DD call

Initial
Vitek
call

WGS
prediction

DD ReTest NEG

Vitek
Re-Test
NEG

DD ReTest
POS

Vitek
Re-Test
POS

Chloramphenicol

R

S

R

R (9mm)

R

R (6mm)

R

Gentamicin

I

S

R

I (15mm)

I

R (6mm)

R

*Lincomycin/
Clindamycin

R

R

R

R

R

R

R

R

Chloramphenicol

S

S

S

S

S

S

S

S

Gentamicin

S

S

R

Rdelayed

S
(17.5mm)

I

R (6mm)

R

*Lincomycin/
Clindamycin

R

R

R

R

R (6mm)

R

R (6mm)

R

NA12

Chloramphenicol

S

S

S

S

S

S

S

S

NA12

Gentamicin

S

S

R

Rdelayed

I (13mm)

I

R (6mm)

R

NA12

*Lincomycin/
Clindamycin

S

S

R

R (Lin)

S (21.5)

S

S
(22mm)

S

NA07

Chloramphenicol

S

S

S

S

S

S

S

S

NA07

Gentamicin

S

S

R

Rdelayed

S (16mm)

S

R (6mm)

R

NA07

*Lincomycin/
Clindamycin

R

R

R

R

R (6mm)

R

R (6mm)

R

Strain
081661
081661
081661
063228
063228
063228

Media
Growth
Rdelayed
Rdelayed
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The in vitro growth assay using chloramphenicol and gentamicin indicated
there may be inducible or dose-dependent resistance in some of these isolates.
Negative controls ensured that increasing resistance to the antibiotics was not a
result of mutations accumulated over time while growing in increasing
concentrations of antibiotics. Stability of the antibiotics was ensured using
negative controls allowed to incubate significantly longer than the experimental
samples. While NA47 served as a control for gentamicin as it lacked both
aminoglycoside resistance genes of interest, it is worth noting that NA45 was
also unable to grow in any concentration of gentamicin. As mentioned before,
NA45 contains the same ant(6)-Ia aminoglycoside resistance gene as the other
North American isolates, it does not contain the aac(6’)-aph(2’’)-Ia gene carried
by the prophage in the isolates that demonstrated resistance to gentamicin. This
supports the conclusion that ant(6)-Ia does not provide general aminoglycoside
resistance and that aac(6’)-aph(2’’)-Ia is likely responsible for resistance to
gentamicin. The North American isolates that have aac(6’)-aph(2’’)-Ia had
susceptible or intermediate initial determinations to gentamicin, but over time
demonstrated resistance when exposed to gentamicin. Taken together, this could
indicate that the aac(6’)-aph(2’’)-Ia gene carried on the prophage provides
gentamicin-inducible resistance.
To rule out indirect resistance effects to gentamicin such as reduced ion
flow through the outer cell wall that may have arisen while being subcultured
repeatedly in liquid media, the media (NEG) and plate (NEG) control was
implemented. It is interesting that 3 of the 4 isolates were interpreted as
intermediate with the Vitek method and 2 out of 4 were interpreted as
intermediate via disc diffusion. This would suggest that there was some level of
resistance provided by growth in liquid media. However, as the negative controls
did not display resistance when cultured in the growth assay without selection,
the growth assay itself does not confer resistance indirectly. Perhaps growth in
liquid media exposes the isolates to conditions similar (less or more stress) to
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those that would exist during an infection, increasing expression of the aac(6’)aph(2’’)-Ia gentamicin resistance gene. However, the results from the media
(POS) and plate (NEG) method were conclusively more resistant in each case,
with determinations for all 4 isolates using both methods being resistant,
including the 3 susceptible interpretations from the media (NEG) plate (NEG)
testing. Additional testing using a media (POS) and plate (POS) was not
necessary as the interpretations from the media (POS) plate (NEG) testing were
the highest level of resistance that could be determined by these assays. It is
worth noting that the isolates grown in both chloramphenicol and gentamicin
selective media were plated for 24 hours on a non-selective plate prior to testing
in this protocol. A loss of resistance when removed from selection may take more
time than 24 hours.
Conversely, when isolate 08-1661 was grown in chloramphenicol and
tested for gentamicin, a reduction in resistance to gentamicin was observed. This
could reflect an unknown enzymatic reaction or cell process, or that energy being
used for generation of chloramphenicol acetyltransferase led to a reduction in
expression of resistance to gentamicin. In theory, this means that co- or serialtreatment strategies may in fact have some success in organisms with multiple
resistances.
Isolate 08-1661 was the only isolate predicted to contain the
chloramphenicol acetyltransferase (CAT) gene, which appeared to be carried on
an extrachromosomal plasmid. While the initial disc diffusion determination was
resistant, the Vitek result indicated susceptibility. However, the Vitek card
available at the time of testing was not validated for chloramphenicol for S.
pseudintermedius, possibly because this conflict in testing had been observed
previously. When exposed to chloramphenicol, 08-1661 displayed resistance
only after 24 hours but less than 72. This may explain the conflict in the initial
testing, as the microbroth dilution assay tests samples at time points as low as 4
hours relative to the disc diffusion 24 hour reading. In the media (NEG) and plate
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(NEG) experiment, resistance was in fact determined to be present using both
methods, although the zone size for the disc diffusion was slightly larger than it
was for the media (POS) plate (NEG) experiment. As the negative controls (all 3
other isolates) remained susceptible via both assays when re-tested in media
(NEG) plate (NEG) experiments, it again suggests that the observed increase in
resistance to chloramphenicol after non-selective growth in media is a result of
an increase in expression of inherent resistance and not an indirect byproduct of
the growth methodology.
The observed delay in resistance to gentamicin by all experimental
isolates (08-1661, 06-3228, NA12 and NA07) with neither negative control (NA45
and NA47) showing resistance in any assay leads to the conclusion that they do
in fact retain inherent resistance to gentamicin but it may not be detected when
tested at time points less than 24 hours. Each isolate displayed variable time
points at which they passed the growth threshold of OD>0.5 in selection at each
concentration. This likely reflects minute differences in heterogeneous
populations, very small differences in inoculating cell numbers or slightly different
time points in growth phase at which inoculum was taken. The time points of 24,
48 and 72 hours were selected due to this variability and the fact that current
assays use a maximum of 24 hour readings.
The location of the resistance genes within the genome (or
extrachromosomally) may suggest a mechanism for this observed inducible
resistance. As stated previously, the CAT gene resides on a plasmid in 08-1661
which based upon average read depth of the initial genome sequencing and the
inability to visualize it from multiple plasmids extractions must be, if present, in
very low copy numbers. The read depth of the original WGS for this plasmid
compared to the genome average is roughly 3x higher, suggesting a likely copy
number of 3 copies per genome. The read depth in the second round of
sequencing, from the culture of 08-1661 that was grown in selection, was 10x the
previous depth, suggesting a copy number per genome of around 30-40. While
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that is still a relatively small copy number for extrachromosomal plasmids, it
could potentially allow significantly increased levels of resistance to
chloramphenicol. If the increase in resistance to chloramphenicol seen in 081661 was due to an increase in plasmid copy number, we would expect to see an
increase in both the DNA sequence of the CAT gene as well as an increase in
the CAT RNA production relative to a housekeeping gene. If however an
increase in RNA is observed but not one in the DNA, it may be that only
expression of the gene has increased and not plasmid copy number.
Alternately, the gene of interest for resistance to aminoglycosides,
specifically gentamicin, are both located on the chromosome. The aac(6’)aph(2’’)-Ia fusion gene resides within unique prophage sequence in each
genome. The gene aph(3’)-III is also found in each of these isolates and
annotated as “aminoglycoside resistance”, yet it has been proven to provide
direct resistance only to kanamycin, neomycin, paromycin, amikacin and
gentamicin B (102). Gentamicin B is a minor component of many commercially
available gentamicin antibiotic solutions yet has an unknown mechanism of
action as it is a terminal alternate pathway in gentamicin production (119). While
gentamicin B does occur in some gentamicin antibiotic solutions, it has not been
shown in Staphylococcus to confer direct resistance to the major gentamicin
component in most commercial solutions. The fusion gene aac(6’)-aph(2’’)-Ia
which provides resistance to gentamicin, tobramycin and amikacin in
Staphylococci and Enterococci is the logical target for conferring gentamicin
resistance in these isolates; that correlates to the resistance patterns we observe
with the exception that instead of providing high level resistance (HLR), it seems
to provide low level or transient resistance. The sequence of this gene does not
contain any synonymous mutations relative to many other sequences in
Genbank and so it is likely that the mechanism is either gene duplication or
increased gene expression. Gene duplication is likely as prophage can in fact
duplicate themselves within a genome especially when under stress, and
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possibly cut themselves out when cell fitness is adversely affected. However, in
these genomes, there are several annotated stress response regulatory genes
surrounding the aac(6’)-aph(2’’)-Ia gene, which could simply provide increased
expression when stressed by the antibiotic. If gene copy number is the reason
behind the increased resistance, both DNA and RNA expression levels would be
expected to increase relative to a housekeeping gene. If increased gene
expression is responsible, an increase in RNA but not DNA would be seen.
While plasmid copy number can be regulated by a variety of factors and
can easily be reduced and increased, genomic expansion doesn’t have a readily
available explanation as to how, if resistance is gained through duplication of
phage or transposons, that duplication would be lost when not under selection in
order to retain energy efficiency. One answer could be in a study that found a
transposon carrying an antibiotic resistance gene duplicated itself up to 90 times,
contributing an extra 300,000+bp to the genome, after exposure to the antibiotic
during treatment. The authors, and namely the person responsible for the optical
map data which discovered and verified the duplications, found that a variety of
resistant clones from the same original colony when subcultured had varying
degrees of gene expansion (120). This would indicate heterogeneous
populations of bacteria exist within an individual sample.
While gene and DNA loss from the genome is typically done through
pseudogenization, that process can take a long time and leaves behind remnants
of the duplications. However, if bacteria that did not contain duplications for the
resistance gene were able to survive within a larger population that had gained
the duplications and thus resistance during selection, they may outcompete the
resistant genotypes if removed from the selective environment. In this theoretical
case, it would seem as though the isolate rapidly loses resistance when in fact a
rapid change in heterogeneous population makeup could happen instead. There
is some indirect evidence that this has happened with strains 08-1661 and 063228. These were subjected to an additional experiment where they were grown
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in selective media and sent directly for disc diffusion and microbroth dilution
testing without going onto a non-selective BA plate first (Materials and Methods,
Figures 22, 23).As NA45 and NA47 grew as expected, the failed growth of 081661 and 06-3228 is either a result of the presence of minute amounts of carryover antibiotic in 06-3228 and 08-1661 somehow affecting growth on MuellerHinton plates or potentially inefficient growth of the majority of the population
from the selective media. For both isolates, most of the plate surfaces were
either empty of obvious bacterial lawn or nearly so, with the exception of
infrequent large colonies.
This evidence supports the following scenario; first, a majority-susceptible
population (containing only 1 copy of the resistance gene) was picked from a
non-select BA plate and used to inoculate media with selection. After some
delay, many cells or a small portion duplicated the resistance gene in order to
become more resistant and successful in the media. When taken from the
selective environment and plated onto the Mueller-Hinton agar directly, a very
small population retained the original single-copy genome variant and were able
to grow normally at 24 hours, while the multi-copy resistant variants were unable
to grow sufficiently due to the large and abnormal energy consumption from the
resistance gene duplication and expansion. Picking the large, normal susceptible
colony from the plate resulted in a higher proportion of large colonies at 24 hours
but still contained the inefficient resistant clones (as they were likely under or
mixed in with the large colony). This gave rise to two distinct populations upon replating. The lawn, containing only the resistant, small colonies, resulted in a more
uniform yet small colony variant when re-plated.
If in fact this phenomena of a heterogeneous population is responsible for
these observations, it would also explain the variability observed in duplicate and
replicate growth experiment timelines for length of time until log phase growth. If
gene duplication is responsible for increased resistance, it is likely that either a)
several independent cells acquire the duplications randomly and each culture is
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unique, or b) an extremely small portion of the cell population has gene
duplications and small differences in inoculating numbers would have a
consequently large effect on growth each time the experiment is performed.
Many attempts were made to inoculate with the exact same number of cells, the
same time of day, the same time points, the same volume, the same
concentration of antibiotic and the same incubation conditions yet variation in
growth in gentamicin still varied even between triplicates in the same experiment.
Lincomycin was also used to test isolates 08-1661, 06-3228, NA12 and
NA07 using the novel in vitro growth assay with NA45 used as a negative control.
As isolates 06-3228, NA12 and NA07 all contained a plasmid encoding the
lincomycin resistance gene LinA (alias lnuA), they should have demonstrated
resistance to lincosamides. Clindamycin is used as a representative for
lincosamides; 08-1661 lacked the gene/plasmid yet was determined to be
resistant using both assays, with no observed growth delay. It should be noted,
however, that there are other genes encoding resistance to clindamycin, such as
the emr(A/B/C/E) family, of which multiple were found in each isolate. Thus, it
isn’t surprising that 08-1661, 06-3228 and NA07 displayed resistance in all initial
and follow-up testing. However, NA12 was interpreted as susceptible using both
disc diffusion as well as microbroth dilution in initial testing, which was
unexpected as it contains not only LinA on a plasmid which may confer
resistance to lincosamides, but an additional plasmid with the emr(E) gene that
belongs to a well-known family of genes conferring resistance through efflux
pumps to multiple antibiotics as well as quaternary ammonium compounds
(QACs), although this particular allele hasn’t been well studied. It does contain
significant homology to qacG which has been implicated in resistance to multiple
biocides and antibiotics (121).
Isolate 08-1661, despite being resistant to clindamycin throughout the
experiment, was unable to grow in the lincomycin used in the growth assay.
Conversely, NA12 was able to grow at 24 past log phase in lincomycin. NA45
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served as a good negative control with no growth past 72 hours while NA07 and
06-3228 growing within 24 hours in media. The two findings here that are
unexpected are first that 08-1661 was unable to grow in lincomycin despite being
resistant to clindamycin, and second that NA12 was able to grow in lincomycin
yet unable to demonstrate any resistance to clindamycin at any time. The
conclusion drawn from this experiment is that clindamycin resistance is not
directly tied to resistance to lincomycin, and vice versa. The reason why NA12
was susceptible in all assays to clindamycin despite being resistant to lincomycin
as well as possessing two genes involved in resistance to lincosamides remains
unknown.
These growth experiments demonstrate that potential clinically relevant
resistance may exist in bacterial isolates even when determined to be
susceptible using standardized antibiotic resistance assays. Two CLSI approved
methods, disc diffusion and microbroth dilution, were compared to a novel mediabased time-delay growth experiment where the critical factor was allowing the
bacteria to grow past the 24 and 4 hour time points, respectively, that each
standard assay is limited to. Not only were resistances predicted on gene content
from WGS data demonstrated where susceptible interpretations were initially
made using one or both methods, but the isolates were able to exhibit in some
cases the highest level of resistance able to be measured. The most significant
findings of resistance to gentamicin and chloramphenicol displayed a delay in
expression up to 72 hours after exposure to the antibiotic, yet were able to
maintain this resistance when removed from selection and placed back into the
standard susceptibility testing techniques. The genes likely responsible for the
resistance observed are located on mobile genetic elements which may function
by increasing copy number or gene expression. One piece of evidence to support
this is the RT-PCR performed on isolate 08-1661 grown in selection displaying
higher plasmid copy number relative to 16s sequence than when not grown in
selection (Figure 30).
100

Chapter Four:
Results and Conclusions
Genome Sequencing as a Tool for Phenotypic Prediction
In this project, clinical isolates of Staphylococcus pseudintermedius were
screened using standard biochemical and molecular approaches during routine
collection. This organism is important not only as a veterinary pathogen (2; 15;
20; 21) but increasingly as a human opportunistic pathogen (7, 12, 13) that may
in fact be more commonly causing disease than currently believed (8; 14; 41)
due to a lack of accurate identification tools (8; 45-47). Several collected isolates
of S. pseudintermedius displayed conflicting or unusual phenotypic and genetic
properties or were representative of major successful clonal lineages in North
America and were selected for further investigation using WGS technology
(Table 16).
Molecular typing using any of several different methods is challenging
when trying to compare between studies or collections as no single typing
method for MRSP or MSSP has been agreed upon to date. In this study the
relationships between isolates between an MLST-7 eBURST analysis (83) and a
core genome SNP analysis were very similar (Figure 9, reinforcing the
relationships between the dominant clonal lineages in North America. As both
MLST-7 and core genome SNP analysis rely upon DNA sequence that is highly
conserved and under purifying selection, it is not surprising that the ST
relationships do not necessarily correlate to clinical characteristics of these
isolates. Clinical characteristics include antibiotic susceptibilities and resistances,
virulence and immune evasion and are often carried by mobile genetic elements
under positive selection (84) and thus would not be part of the MLST typing
system nor the core genome analysis.
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Table 16. Overview of All Sequenced Isolates.
A total of 47 genomes were sequenced comprising multiple species and Genera, with a
focus on clinical isolates of S. pseudintermedius. Sequence Type was determined using
the MLST-7 scheme, unless it was unable to be performed (“unknown”) or failed to
generate sequence for all alleles (“N/A”). S. delphini were characterized by “Type” A or
B, respectively. The Justification for sequencing ranged from attempting to identify
isolates unable to be characterized using standard techniques, conflicting genotypes and
phenotypes, comparative analysis of dominant clonal lineages of MRSP and
characterization of the first MRSP isolates from Botswana.
Justification

Contigs

B1549

Sequence
Type
N/A

Unknown species

1

S. species (unknown)

B1553

N/A

Unknown species

1

S. pseudintermedius

117N

unknown

Canine from Botswana

1

S. pseudintermedius

111N

unknown

Canine from Botswana

1

Canine from Botswana

160

S. pseudintermedius

104N
NA45

unknown
ST84

Dominant NA Lineage

89

S. pseudintermedius

06_3228

ST68

Dominant NA Lineage

260

S. pseudintermedius

NA47

ST56

Dominant NA Lineage

54

S. pseudintermedius

NA07

ST124

Dominant NA Lineage

96

S. pseudintermedius

NA12

ST64

Dominant NA Lineage

42

S. pseudintermedius

E15

Electrocompetent

112

S. pseudintermedius

E140

N/A
ST71

44

Species

Strain ID

S. species (unknown)

S. pseudintermedius

ST71

S. pseudintermedius

NA91
08_1661

European ST71
Lytic against
MRSP/MRSA
MecA(-) ST71

ST71

North American ST71

50

S. pseudintermedius

NA16 Pre

N/A

Phage lysis study

39

S. pseudintermedius

N/A

Phage lysis study

43

S. pseudintermedius

NA16 Post
LMG22219

N/A

Type Strain

10

S. pseudintermedius

NA149

ST160

Typing verification

24

S. pseudintermedius

NA63

ST162

Typing verification

41

S. pseudintermedius

S. pseudintermedius
S. pseudintermedius

MI 13-1718

N/A

54
43

NA144

ST56/CC84

Typing verification

55

S. pseudintermedius

NA189

ST159/CC84

Typing verification

51

S. pseudintermedius

NA179

ST148/CC71

Typing verification

20

S. pseudintermedius

NA184

ST80/CC68

Typing verification

18

S. pseudintermedius

NA36

ST154

Typing verification

275

S. pseudintermedius

NA109

N/A

Typing verification

39

S. pseudintermedius

NA104

ST139

Typing verification

77

S. pseudintermedius

NA125

ST141/CC68

Typing verification

22

S. pseudintermedius

NA180

ST106

Typing verification

93
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Table 16 continued.
Justification

Contigs

NA3

Sequence
Type
ST152

Typing verification

37

Species

Strain ID

S. pseudintermedius
S. pseudintermedius

NA77

ST134

Typing verification

39

S. pseudintermedius

NA38

ST142

Typing verification

34

S. pseudintermedius

06-1066A

N/A

Unusual ASP

37

S. pseudintermedius

06-1066B

N/A

Unusual ASP

50

S. pseudintermedius

MI 14-243

N/A

Unusual ASP

36

S. pseudintermedius

NA157
MI 162909a
MI 162925a
NCTC11048

N/A

Unusual ASP

75

N/A

Unusual ASP

52

N/A

Unusual ASP

53

Type Strain

19

Species verification

24

S. pseudintermedius
S. pseudintermedius
S. intermedius
S. delphini

52-006A

N/A
Type A

S. delphini

MI16-1129A

Type A

Species verification

46

S. delphini

56-021A

Type A

Species verification

52

S. delphini

P27B

Type B

Species verification

51

S. delphini

P50
DSM20771

Type B

Species verification

46

N/A
N/A

Type Strain

24

Lab reference strain

99

N/A

Unknown species

65

S. delphini
S. aureus
Caviibacter
abscessus

Wood46
MI 14-3285

It has been suggested that MGEs in Staphylococci are relatively rare and,
when present, conserved within clonal lineages (122; 123). In this study, a novel
method to detect potential plasmids from WGS data directly was used to identify
>30 potential plasmids, of which 9 were studied in depth. As these 9 plasmids
come from only 4 isolates it seems likely that plasmid content in S.
pseudintermedius is much higher than previous studies would suggest. As 3
identical plasmids (LinA) are found across completely different major clonal
lineages (ST64, ST124 and ST68), conservation within lineages of MGE does
not appear to be true and recent horizontal transfer is likely. The results of this
study also conclude that even when these plasmids can be isolated or amplified,
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they are present at very low copy number per genome and easily missed by
more traditional plasmid isolation techniques (64). None of the 9 plasmids
investigated matched to any complete plasmid sequence to date in Genbank,
further proving that using known plasmid sequence to design primers to screen
for plasmids is unlikely to be a good novel plasmid discovery technique. Plasmids
found using this approach will in fact appear lineage-conserved simply because
the screening method requires that they be closely related (64). The novelty of
the majority of plasmids discovered in this study also highlights the likelihood of
rapid and recent horizontal transfer between lineages.
Bacteriophage insertions in the completed genomes of HKU10, ED99,
E140, 08-1661, 06-3228 and NA45 indicate that phage content is not lineage
conserved, which directly conflicts with previous studies (123). When comparing
prophage insertion sites and specific prophage sequences between these
completed genomes two patterns emerge (Appendix C). First, phage insertion
sites within the genome appear to be lineage conserved. However, the actual
prophage sequence within these sites are most similar among isolates that are
geographically related. As insertion sites reflect specific DNA sequence within
each genome, conservation among evolutionarily related organisms is logical
due to their core genome sharing more in common than with other lineages.
However, as bacteriophage are known to move horizontally between bacteria
and do not generally reflect evolutionary relationships, specific phage content is
more closely tied to geographic region than clonal lineage. This conclusion may
have been missed by previous studies simply because repetitive phage
insertions frequently create problems for genome assembly and incomplete
genomes may lack these sequences (85). The inclusion of PacBio long reads as
well as optical genome maps to assist with scaffolding assemblies in order to
close genomes was essential in clarifying these repetitive phage insertions.
Of the major clonal lineage representatives for North America, isolates 081661, 06-3228, NA12 and NA07 appeared to have conflicting antibiotic
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susceptibilities during initial testing using two standardized methods; disc
diffusion and microbroth dilution. Some of these resistances were predicted from
the WGS data to be conferred through genes found in MGEs such as prophage,
transposons and plasmids (Table 8). Isolate 08-1661 was shown to harbor a
plasmid with the chloramphenicol resistance gene CAT yet was interpreted as
susceptible using microbroth dilution. Disc diffusion correctly determined
resistance, and while the Vitek card used was not certified for chloramphenicol
resistance in pseudintermedius it still should have given an MIC within the
resistant range to correlate with disc diffusion. As one major difference between
these techniques is the amount of time the bacteria has to grow before a call is
made, it appeared likely that resistance was time dependent. When exposed to
chloramphenicol in a novel liquid media growth experiment, isolate 08-1661 did
in fact display resistance relative to a negative control but only after 24 hours had
passed from initial exposure. When re-tested using both original clinical assays, it
was determined to be highly resistant.
As the CAT gene was located on a plasmid, one explanation that could
account for a delay in phenotypic resistance would be the necessity of increasing
plasmid copy number. While this was experimentally tested using traditional RTPCR and found to have increased copies of the gene when exposed to
chloramphenicol, a novel WGS approach was also used to assess copy number
variation and reached the same conclusion. When cultures growing in
chloramphenicol were removed from selection and tested using standard clinical
assays, they retained this increased resistance profile for at least 24 hours postexposure.
Isolates 08-1661, 06-3228, NA12 and NA07 all were determined to be
susceptible to gentamicin by at least one standardized test, yet all were found to
carry the aac(6’)-aph(2’’)-Ia aminoglycoside/gentamicin resistance gene. As
opposed to being located on a plasmid, this gene is found within unique
prophage sequence in each of these isolates. Prophage are known to be able to
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duplicate themselves within a genome in response to stress, but several of these
phage also contained stress-response regulatory genes that could up- or downregulate gene expression. As both of these scenarios could potentially take time
to come into effect, these isolates were subjected to the same novel growth
assay but with gentamicin instead of chloramphenicol. All 4 isolates positive for
the aac(6’)-aph(2’’)-Ia gene were in fact capable of high-level resistance to
gentamicin when given >24 hours exposure to the antibiotic, while an isolate
containing two other aminoglycoside resistance genes remained susceptible. As
the aac(6’)-aph(2’’)-Ia gene is known to confer high-level resistance (HLR) to
gentamicin (88), they were re-tested after adaptation to growth in selective media
and were interpreted as resistant at the highest level possible for both
standardized assays (Table 14).
Isolate NA12 was initially interpreted as susceptible to the lincosamide
antibiotic clindamycin, yet WGS revealed that it had two plasmids carrying genes
predicted to confer resistance to lincosamides (Tables 5 and 8). While one of
these plasmids carries the LinA gene which may be specific to lincomycin, the
other was an emrE family gene directly associated with clindamycin resistance
(88; 124; 125). While NA12 was able to demonstrate high level resistance to
lincomycin in the novel growth assay (as were all other isolates), when it was retested using the standard clinical assays with clindamycin it remained
susceptible. This informs on two important points; first, that this gene may not
actually confer resistance to clindamycin despite previous studies, and more
importantly clindamycin is not able to be used to assume lincosamide-class
antibiotic resistance as resistance to lincomycin and clindamycin were shown to
be completely independent.
This study investigated the relationship between phenotype and genotype
among well-characterized clinical isolates of S. pseudintermedius. Whole
genome sequencing and core genome SNP analysis was able to verify
evolutionary relationships between bacteria as determined by the MLST-7 typing
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system providing the highest level of support for this method. Accessary genome
components that do not group by genetic relatedness and are associated with
mobile genetic elements and horizontal transfer were found in all genomes and
did not group by clonal lineage. An average plasmid content of two per genome
was discovered, overturning the commonly held belief that plasmid content is
rare in Staphylococci. Plasmids from distantly related clonal lineages were found
to be identical, and plasmids within closely related lineages were found to be
unique, suggesting that plasmid content is not lineage-conserved in this species
and is likely to move rapidly between sequence types via horizontal transfer.
Prophage content of closed genomes revealed that phage insertion sites are
mostly lineage-conserved, whereas actual specific phage content is more
associated with geography. Both plasmid and phage sequence were able to be
directly identified from WGS data and verified using traditional molecular
methods. Having access to closed genomes was essential in this as repetitive
phage are often missed in genome assemblies while plasmids can be easily
misidentified as unplaced chromosomal contigs.
Increasing resistance to multiple antibiotics has been identified as a global
health concern involving both human and animal medicine (111), with increasing
surveillance and better diagnostics being critical goals in the plan. Here data has
been presented that becoming complacent with standardized assays may lead to
missing critical clinical information such as antibiotic resistance. As we surveille
bacteria at specific time points (4 hours for microbroth dilution, 24 hours for disc
diffusion) for antibiotic resistance and often treat based on these findings, the
pathogens have been provided an impetus to evade detection. One simple way
to do this is to delay expression of high-level or detectable resistance until after
these measurements are taken. While the data presented here cannot show
direct clinical relevance for the detected antibiotic resistance without testing in an
animal model, significant evidence is provided suggesting that they may in fact
be resistant in a manner that has clinical relevance. The observed delay in
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phenotypic resistance in this study taken with the fact that many antibiotic
treatment failures happen 48-72 hours after initiation suggests studies like this
are useful for identifying novel mechanisms of resistance to antibiotics.
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Appendix A. Antibiograms.
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Appendix B. Modified Protocols.
Nextera XT kit, 24, on bacterial genomes for de novo assembly (FASTQ
output). Attempt to scale down to 6 samples; written per
sample/reaction. MCR 30DEC2015.
Extracted from the Nextera XT library prep guide version E:

Tagmentation of Input DNA

Make NTA
1. label microcentrifuge tubes with “NTA” and sample ID
2. Add 10 μl TD Buffer to each sample tube.
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3.
4.
5.
6.
7.
8.

Add 5 μl input DNA at 0.2 ng/μl (1 ng total) to each sample tube.
Gently pipette up and down 5 times to mix.
Add 5 μl ATM to each sample.
Gently pipette up and down 5 times to mix.
Centrifuge at 280 × g at 20°C for 1 minute.
Place samples in a thermal cycler and run the following program:
a. Make sure that the thermal cycler lid is heated during the
incubation.
b. 55°C for 5 minutes.
c. 10°C hold; once sample reaches this, proceed IMMEDIATELY to
next step.

Neutralize NTA
1.
2.
3.
4.
5.

Add 5 μl NT Buffer to each sample.
Gently pipette up and down 5 times to mix.
Centrifuge at 280 × g at 20°C for 1 minute.
Place the sample at room temperature for 5 minutes
[Optional] Assess tagmentation by running 1 μl of sample on an HS
bioanalyzer chip.

PCR Amplification

Make sure that the correct index 1 (i7) and index 2 (i5) primers have been selected. Use
the Illumina Experiment Manager and the Nextera XT DNA Library Preparation LowPlex Pooling Guidelines Tech
Note to confirm the selected index primers.
1. Remove NPM and the index primers (i5 and i7) from -25°C to -15°C
storage and thaw on a bench at room temperature.
2. Allow approximately 20 minutes to thaw NPM and index primers.
3. Gently invert each primer and NPM tube 3–5 times to mix and briefly
centrifuge the tubes in a microcentrifuge.
4. Add 15μl NPM to each sample.
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5. add 5μl index 2 unique [
] primers (white caps) to each sample.
RECORD which index is used for each individual sample.
6. add 5μl index 1 unique [
] primers (orange caps) to each sample, and
mix using pipette. RECORD which index is used for each individual
sample.
7. Centrifuge at 280 × g at 20°C for 1 minute.
8. Perform PCR using the following program on a thermal cycler:
1. (Make sure that the thermal cycler lid is heated during the incubation)
a) 72°C for 3 minutes
b) 95°C for 30 seconds
c) 12 cycles of:
a. 95°C for 10 seconds
b. 55°C for 30 seconds
c. 72°C for 30 seconds
d) 72°C for 5 minutes
e) Hold at 10°C
SAFE STOPPING POINT
If you do not plan to proceed immediately to PCR Clean-Up, there are two options for
storage. The NTA plate can remain on the thermal cycler overnight or you can store it at
2°C to 8°C for up to two days.
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PCR Clean-Up
This step uses AMPure XP beads to purify the library DNA, and provides a size selection
step that removes short library fragments from the population.

1.
2.
3.
4.

Centrifuge samples at 280 × g for 1 min (20˚C) to collect condensation.
Label a new tube CA (Clean Amplified) and sample ID for each sample.
Transfer the PCR product (~50uL) from the NTA tube to the CA tube.
Vortex the AMPure XP beads for 30 seconds to make sure that the beads
are evenly dispersed.
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5. Add 25μl of AMPure XP beads to each CA tube (for 2x300 MiSeq; see
detailed protocol for variation).
6. Gently pipette mix up and down 10 times.
7. Incubate at room temperature without shaking for 5 minutes.
8. Place tubes on a magnetic stand for 2 minutes or until the supernatant has
cleared.
9. Use a multichannel pipette to remove and discard the supernatant
carefully.
10. wash the beads with freshly prepared 80% ethanol as follows:
a. add 200 μl freshly prepared 80% ethanol to each sample
b. Let stand 30 seconds.
c. Remove excess ethanol (Use a P20 multichannel pipette with fine
pipette tips to remove excess ethanol).
2.
11. Repeat wash step (step 10). Use a P20 multichannel pipette with fine
pipette tips to remove excess ethanol.
12. While still on the magnetic stand, allow the beads to air-dry for 15 minutes.
13. Remove tubes from magnetic stand.
14. Add 52.5 μl RSB to each sample, Gently pipette mix up and down 10
times.
15. Incubate at room temperature for 2 minutes.
16. Place the plate on the magnetic stand for 2 minutes or until the
supernatant has cleared.
17. Label a new tube CAN (Clean Amplified NTA) and sample ID.
18. Transfer 50 μl of the supernatant from the CA tube to the CAN tube.
SAFE STOPPING POINT
If you do not plan to proceed to Library Normalization immediately, seal the CAN tubes
and store it at -25°C to -15°C for up to a week.
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Library Normalization
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Preparation (Illumina recommends performing the LNA1 preparation step under a
fume hood)
1. Remove LNA1 from -25°C to -15°C storage and bring to room
temperature. Use a 20°C to 25°C water bath as needed. LNA1 might form
visible precipitates or crystals. Before use, vortex vigorously, and then
hold the tube in front of a light and visually inspect to make sure that all
precipitate has dissolved.
2. Remove LNB1 and LNW1 from 2°C to 8°C storage and bring to room
temperature. Use a 20°C to 25°C water bath as needed.
3. Vigorously vortex LNB1 for at least 1 minute with intermittent inversion.
Repeat this step until the beads are well-resuspended and no pellet is
found at the bottom of the tube when the tube is inverted. Make sure that
LNS1 is at room temperature before use.

Elute LNP
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1. Label a new tube LN (Library Normalization) and sample ID.
2. Transfer 20 μl of the supernatant from the CAN tube to the LN tube.
3. Prepare master mix (MM) of LNA1 and LNB1 (per sample):
a. Add 45.8µL LNA1 and 8.33µL LNB1 per sample. LNB1 is a
precipitate (beads, see important note below), so prepare master
mix first for LNA1 per this example (6 samples chosen):
i. 45.80µL LNA1 per sample; 6 samples= 274.8µL LNA1 into
MM tube.
ii. 8.33µL LNB1 per sample; 6 samples= 49.98uL; add to LNA1
MM tube** SEE BELOW
3.
4. IMPORTANT: Before adding LNB1, use 1000µL pipette set to 1000µL to
mix LNB1 thoroughly. DO NOT USE 100-200µL pipette to transfer <100µL
(always use either a 1000µL pipette tip, or a 200µL tip cut off for larger
bore size (or large bore pipette). So, in this example of adding 49.98µL
LNB1 to the 274.8µL LNA1, use a cut off/large bore 200µL tip to transfer
the ~50µL LNB1.
5.
4. Add 45 μl combined LNA1/LNB1 to each LN tube containing libraries.
5. Shake at 1800 rpm for 30 minutes at room temperature.
a. NOTE: The 30 minute incubation is critical for proper library
normalization. Incubations of greater or less than 30 minutes can
affect library representation and cluster density.
6. Place tubes on a magnetic stand for 2 minutes and confirm that the
supernatant has cleared.
7. use a pipette set to 80 μl to remove the supernatant and then discard in an
appropriate hazardous waste container.
8. Remove the LN tube from the magnetic stand and wash the beads with
LNW1, as follows:
a. add 45μl LNW1 to each sample
b. shake at 1800 rpm for 5 minutes
c. Place on the magnetic stand for 2 minutes or until the supernatant
has cleared.
d. remove and discard the supernatant
9. REPEAT step 8 for a second LNW1 wash.
10. Remove the LN tube from the magnetic stand and add 30 μl 0.1 N NaOH
(fresh stock solution) to each well to elute the sample.
11. Shake at 1800 rpm for 5 minutes.
a. While the elution is shaking, label new tubes with SG (Storage) and
Sample ID.
b. Add 30μl LNS1 to each SG tube.
12. After 5 minute incubation with shaking LN tubes, place LN tubes on the
magnetic stand for 2 minutes or until the liquid is clear.
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13. Using a pipette set to 30μl, transfer the supernatant from the LN elution
tubes while on the magnetic rack to the SG tube containing the 30µL
LNS1.
14. Centrifuge to 1000 × g for 1 minute.
SAFE STOPPING POINT
If you do not plan to proceed to Library Pooling and MiSeq Sample Loading
following the
completion of Library Normalization, store the sealed SGP plate at -25°C to -15°C
for up
to one week.
NOTE
Because the final library pool consists of single-stranded DNA, it does not resolve
well
on an agarose gel or Bioanalyzer chip. qPCR can be used for quality control if
desired.
For more information, please see the Sequencing Library qPCR Quantification Guide
(part #
11322363).
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Appendix C. Prophage Genome Insertion Locations.
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